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Abstract 
 
According to the European Working Group on Sarcopenia in Older People 
(EWGSOP), sarcopenia is a condition defined as the loss of both muscle mass and 
muscle function (strength or performance). Sarcopenia is a complex phenomenon 
and there are several factors associated with the development of this condition. 
Sarcopenia is diagnosed using muscle mass, strength and physical 
performance data. There is lack of standardization of the diagnostic procedures, but 
this classification can be improved. Nevertheless, prevalence of sarcopenia varies 
widely depending on the methodology used for its diagnosis. Moreover, although 
sarcopenia is mainly considered as a geriatric syndrome, this condition has been 
also reported as being present in younger adults. However, the problem of 
sarcopenia among hospitalized younger adults remains to be documented. 
Sarcopenia has been previously described as being related with poor clinical 
outcome in hospitalized patients. However, in regards to the association of 
sarcopenia with length of hospital stay, information is scarce and controversial. 
Moreover, data on financial burden of sarcopenia in hospital setting is limited to 
surgical patients.  
Concerning the assessment of hospitalized patients, anthropometry provides 
useful information on body composition and is of utmost importance in nutrition risk 
screening and evaluation. Even though anthropometric measures, such as body 
circumferences and skinfold thickness, are not considered by the EWGSOP as 
being suitable for routine use in clinical practice, they still are amongst the most 
relevant methods for body composition assessment due to their predictive value and 
their practicability. Therefore, reducing potential sources of error in body 
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circumferences and skinfold thickness assessment would be advantageous in order 
to provide a more valid and broader use of anthropometry. 
The present thesis aims to evaluate the frequency of sarcopenia among 
hospitalized patients and to study the impact of different diagnostic criteria on 
sarcopenia diagnosis (paper 1). It also aimed to identify factors associated with 
sarcopenia and to increase the knowledge about clinical (paper 2) and financial 
impact (paper 3) of sarcopenia among hospitalized patients. Furthermore, the 
present work aimed to explore potential sources of error in the assessment of body 
circumferences (paper 4) and skinfold thickness (paper 5). 
The first three studies that compose the present thesis were conducted 
among a consecutive sample of respectively 608, 655 and 656 hospitalized patients 
aged ≥18 years. Studies 4 and 5 were conducted among a convenience sample of 
123 and 106 patients, respectively. The design of studies 1, 4 and 5 is 
cross-sectional, while studies 2 and 3 are prospective. 
Paper 1 results showed that 25.3% patients were sarcopenic. However, 
depending on age and on the applied criteria, frequency of sarcopenia varied from 
5% to 41.1% for men and from 4.9% to 38.3% for women. There was 95.7% (k = 
0.89) agreement between criteria that estimated muscle mass by bioelectrical 
impedance analysis. According to the EWGSOP criteria, approximately 20% of the 
non-undernourished patients were sarcopenic and 29.5% of the overweight and 
18.7% of the obese patients were also sarcopenic. Furthermore, 19.8% patients 
aged 18 to 64 years were sarcopenic. 
Factors associated with sarcopenia (Paper 2) were male gender, age ≥65 
years, moderate or severe dependence, undernutrition and being admitted to a 
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medical ward. Sarcopenic patients presented a lower probability of being discharged 
home (Hazard Ratio (HR), 95% Confidence Interval (CI) = 0.71, 0.58-0.86). 
However, after stratifying for age groups, this effect was visible only in patients aged 
<65 years (HR, 95% CI= 0.66, 0.51-0.86). Moreover, sarcopenic overweight or 
obese patients presented a higher probability of being discharged home (HR, 95% 
CI = 0.78, 0.61-0.99) than non-overweight sarcopenic patients (HR, 95% CI = 0.63, 
0.48-0-83). 
Paper 3 showed that sarcopenia independently increased hospitalization 
costs by €1240 (95 % CI: €596-1887) for patients aged <65 years and €721 (95% 
CI: €13-1429) for patients aged ≥65 years. Sarcopenic overweight was also 
independently related to an increase in hospitalization costs of €884 (95% CI: 
€295-1476). 
Regarding the effects of posture and body mass index on body girths 
assessment (paper 4), body girths obtained in the supine and standing positions 
were compared according to body mass index (BMI) normal weight and overweight 
categories. Significant differences were found between measurements obtained in 
standing and supine positions, ranging from 0.6 to 1.1 cm. Intraclass correlation 
coefficient values were ≥0.97 and agreement ranged from 81.3% to 87% (weighted 
k ≥0.84). Similar results were found when differences were stratified by BMI 
categories. 
The aim of paper 5 was to explore and describe, through an innovative 
technique, triceps skinfold (TSF) compressibility and its associated factors among a 
sample of hospitalized patients. Compressibility was determined according to a 
definition based on a measurement of time (τ) that reflects adipose tissue dynamic 
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response to compression, and it was also defined according to the difference 
between the initial and  final TSF value (TSF difference). Results from multivariable 
linear regression models showed that time of compressibility (τ) was not significantly 
associated with any of the included variables, but compressibility based on 
difference of TSF values was independently associated with TSF thickness 
(regression coefficient (95% Confidence Interval) = 0.38 (0.01-0.05), p=0.002) and 
with nutritional status (regression coefficient (95% Confidence Interval) = 0.23 
(0.12-1.23), p=0.018).  
The present work results lead to the following conclusions: (1) sarcopenia is 
frequent among hospitalized patients and this frequency varies widely depending 
on the applied diagnostic criteria; sarcopenia was identified in a considerable 
proportion of adult patients aged between 18 and 64 years and in those who were 
non-undernourished, namely among overweight and obese; (2) being male, aged 
≥65 years, being dependent, being undernourished and being admitted to a medical 
ward were factors associated with sarcopenia among hospitalized adult patients; 
sarcopenia is independently associated with longer LOS, although this association 
is stronger for patients aged 18 to 64 years; moreover, sarcopenic overweight was 
associated with a higher probability of discharge home than non-overweight 
sarcopenia; (3) sarcopenia is independently associated with hospitalization costs, 
increasing hospitalization costs in 52.7% (58.5% for patients aged < 65 years and 
34% for patients aged ≥ 65 years); (4) body girths assessment in standing and 
supine positions in hospitalized adults and older adults differ. However, these 
differences are small and they are not dependent on BMI categories; (5) among a 
sample of hospitalized patients, time of compressibility (τ) was not related with any 
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of the studied factors. However, undernutrition risk and the TSF thickness were 
factors independently associated with higher compressibility assessed by the 
difference between the initial and final TSF value. Although this is an exploratory 
attempt to describe compressibility and its associated factors, our results emphasize 
the need for further research in order to determine the most accurate method to 
quantify compressibility, to infer on the associated factors and to control its effect. 
The present work results increased the knowledge on the burden and on the 
diagnostic criteria of sarcopenia in a clinical perspective and demonstrated that this 
condition is not merely a geriatric syndrome on a hospital setting. Moreover, the 
recognition of small posture and physical complexion related errors associated to 
body girths assessment and the advancement in the possibility to quantify skinfolds 
compressibility may be useful insights concerning the use of anthropometric 
measures. 
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Resumo 
 
O European Working Group on Sarcopenia in Older People (EWGSOP) 
define a sarcopenia como a perda de massa e de função muscular (força ou 
desempenho). A sarcopenia é um fenómeno complexo e existem diversos fatores 
associados ao desenvolvimento desta condição. 
O diagnóstico da sarcopenia é realizado através da avaliação da massa e da 
força muscular e do desempenho físico. Não existem procedimentos de diagnóstico 
padronizados, mas este processo poderá ser otimizado. Todavia, a prevalência da 
sarcopenia apresenta grande variação, dependendo do método seguido para o seu 
diagnóstico. Para além disso, embora a sarcopenia seja geralmente considerada 
uma síndrome geriátrica, esta condição foi já descrita como estando presente em 
adultos mais jovens. Contudo, o problema da sarcopenia em adultos jovens 
hospitalizados não foi ainda documentado. 
A sarcopenia foi anteriormente relacionada com pior prognóstico em doentes 
hospitalizados. Porém, relativamente à associação da sarcopenia com o tempo de 
internamento, a informação atualmente existente é escassa e controversa. Além 
disso, a informação sobre o impacto económico da sarcopenia em contexto 
hospitalar é limitada a doentes cirúrgicos. 
 Relativamente à avaliação de doentes hospitalizados, a antropometria 
fornece informação de grande utilidade sobre a composição corporal e é da maior 
importância no rastreio do risco nutricional e na avaliação do estado nutricional. 
Embora as medições antropométricas, como os perímetros corporais e as pregas 
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cutâneas, não sejam consideradas pelo EWGSOP como adequadas para utilização 
por rotina na prática clínica no diagnóstico da sarcopenia, estão entre os métodos 
mais relevantes para a avaliação da composição corporal, devido ao seu valor 
preditivo e fácil aplicabilidade. Assim, a redução de potenciais fontes de erro na 
avaliação de perímetros corporais e de pregas cutâneas, poderá ser vantajosa, uma 
vez que poderá permitir melhorar a validade da antropometria. 
A presente tese tem como objetivo avaliar a frequência da sarcopenia e 
estudar o impacto de diferentes critérios de diagnóstico (artigo 1). Este trabalho 
teve também como objetivo identificar os fatores associados com a sarcopenia e 
aumentar o conhecimento acerca do seu impacto clínico (artigo 2) e económico 
(artigo 3) em doentes hospitalizados. Foram ainda objetivos deste trabalho explorar 
potenciais fontes de erro na avaliação de perímetros corporais (artigo 4) e de 
pregas cutâneas (artigo 5). 
Os primeiros três estudos que compõem esta tese foram conduzidos numa 
amostra consecutiva de, respetivamente, 608, 655 e 656 doentes hospitalizados 
com idade igual ou superior a 18 anos. Os estudos 4 e 5 foram conduzidos numa 
amostra de conveniência de 123 e 106 doentes, respetivamente. Os estudos 1,4 e 
5 são transversais, enquanto os estudos 2 e 3 são prospetivos. 
Os resultados do artigo 1 mostram que 25,3% dos doentes avaliados 
encontravam-se sarcopénicos. No entanto, dependendo da idade e do critério 
aplicado, a frequência da sarcopenia variou de 5% a 41,1% nos homens e de 4,9% 
a 38,3% nas mulheres. Encontrou-se uma concordância de 95,7% (k = 0,89) entre 
os critérios que estimaram a massa muscular através de impedância bioelétrica. 
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De acordo com os critérios do EWGSOP, aproximadamente 20% dos 
doentes não desnutridos encontravam-se sarcopénicos e 29,5% dos doentes com 
excesso de peso e 18,7 % dos doentes obesos estavam também sarcopénicos. 
Além disso, 19,8% dos doentes com idade compreendida entre os 18 e os 64 anos 
encontravam-se sarcopénicos. 
Os fatores associados com a presença de sarcopenia (artigo 2) são o sexo 
masculino, idade igual ou superior a 65 anos, dependência moderada ou grave, 
desnutrição e admissão hospitalar num serviço médico. Os doentes sarcopénicos 
apresentam menor probabilidade de ter alta do hospital (Hazard Ratio (HR); 
Intervalo de Confiança (IC) 95% = 0,71; 0,58-0,86). No entanto, após estratificação 
por grupos etários, este efeito foi visível apenas nos doentes com idade 
compreendida entre os 18 e os 64 anos (HR; IC 95% = 0,66; 0,51-0,86). Além disso, 
doentes com excesso de peso sarcopénico ou obesidade sarcopénica 
apresentaram maior probabilidade de ter alta (HR; IC 95%= 0,78; 0,61-0,99) do que 
os doentes sarcopénicos sem excesso de peso ou obesidade (HR; IC 95% = 0,63; 
0,48-0,83). 
O artigo 3 mostra que a sarcopenia aumenta de forma independente os 
custos de hospitalização em €1240 (IC 95%: €596-1887) nos doentes com idade 
compreendida entre 18 e 64 anos e em €721 (IC 95%: €13-1429) nos doentes com 
65 ou mais anos. O excesso de peso sarcopénico associou-se a um aumento 
independente de €884 (IC 95%: €295-1476) dos custos de hospitalização.  
Quanto aos efeitos da postura e do índice de massa corporal (IMC) na 
avaliação de perímetros corporais (artigo 4), os perímetros corporais obtidos na 
posição ortostática e em decúbito dorsal foram comparados de acordo com duas 
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categorias de IMC: peso normal e excesso de peso ou obesidade. Encontraram-se 
diferenças significativas entre 0,6 e 1,1 cm, entre as medições obtidas em posição 
ortostática e em decúbito dorsal. Os valores dos coeficientes de correlação 
intraclasse foram ≥0,97 e a concordância variou de 81,3% a 87% (k ponderado 
≥0,84). Obtiveram-se resultados semelhantes quando as diferenças foram 
estratificadas por categorias de IMC. 
Com o artigo 5 pretendeu-se explorar e descrever, através de uma técnica 
recentemente desenvolvida, a compressibilidade da prega cutânea tricipital (PCT) 
e os seus fatores associados numa amostra de doentes hospitalizados. A 
compressibilidade foi determinada de acordo com uma definição baseada numa 
medida de tempo (τ) que reflete a resposta dinâmica do tecido adiposo à 
compressão, e foi também definida de acordo com a diferença entre o valor inicial 
e o valor final da PCT (diferença de PCT). Resultados provenientes de modelos de 
regressão linear mostraram que o tempo de compressibilidade (τ) não se encontra 
significativamente associado com nenhuma das variáveis incluídas. Contudo, a 
compressibilidade baseada na diferença de valores da PCT encontra-se 
independentemente associada com a espessura da PCT (coeficiente de regressão 
(intervalo de confiança a 95%) = 0,38 (0,01-0,05), p=0,002) e com o estado 
nutricional (coeficiente de regressão (intervalo de confiança a 95%) = 0,23 
(0,12-1,23), p=0,018).  
Os resultados do presente trabalho conduzem às seguintes conclusões: (1) 
a sarcopenia é frequente em doentes hospitalizados e esta frequência apresenta 
grande variação, dependendo do critério de diagnóstico aplicado; identificou-se a 
sarcopenia numa proporção considerável de doentes adultos com idade 
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compreendida entre os 18 e os 64 anos e também em doentes não desnutridos, 
com excesso de peso e em obesos; (2) ser do sexo masculino, com idade igual ou 
superior a 65 anos, apresentar dependência, estar desnutrido e ser hospitalizado 
num serviço médico são fatores associados à presença de sarcopenia em doentes 
adultos hospitalizados; a sarcopenia encontra-se independentemente associada a 
maior tempo de internamento, embora esta associação seja mais forte em doentes 
com idade compreendida entre os 18 e os 64 anos; o excesso de peso sarcopénico 
relaciona-se com maior probabilidade de ter alta do que a sarcopenia não 
associada com excesso de peso; (3) a sarcopenia associa-se de forma 
independente com os custos de hospitalização, aumentando-os em 52,7% (58,5% 
em doentes com idade inferior a 65 anos e 34% em doentes com 65 ou mais anos); 
(4) a avaliação de perímetros corporais em posição ortostática e em decúbito dorsal 
em doentes hospitalizados difere mas estas diferenças são pequenas e não 
dependem das categorias de IMC; (5) numa amostra de doentes hospitalizados, o 
tempo de compressibilidade (τ) não se encontrava associado com nenhum dos 
fatores estudados. No entanto, o risco de desnutrição e a espessura da PCT são 
fatores independentemente associados com um aumento da compressibilidade, 
definida como a diferença entre o valor inicial e o valor final de PCT. Embora se 
trate de uma análise exploratória para descrever a compressibilidade e os seus 
efeitos, estes resultados realçam a necessidade de mais investigação de forma a 
determinar o método mais preciso para quantificar a compressibilidade, para inferir 
sobre os fatores associados e controlar o seu efeito.  
Os resultados da presente tese aumentaram o conhecimento acerca do 
problema e dos critérios de diagnóstico da sarcopenia numa perspetiva clínica e 
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demonstraram que esta condição não é meramente uma síndrome geriátrica em 
contexto hospitalar. Além disso, o reconhecimento dos pequenos erros associados 
à postura e à compleição física na avaliação de perímetros corporais e o avanço na 
possibilidade de quantificar a compressibilidade de pregas cutâneas poderão ser 
indicações úteis no que concerne à utilização de medições antropométricas. 
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Introduction 
1. Sarcopenia 
 
1.1. Definition: definition and diagnosis 
 
The term “sarcopenia” (from the Greek, sarx, flesh and penia, loss) was firstly 
proposed by Irwin Rosenberg in 1989 (1) in order to describe age-related decline of 
muscle mass. Since then, muscle strength has been added as a possible diagnostic 
parameter (2). However, a widely accepted definition of sarcopenia suitable for use 
in both research and clinical practice was still lacking. 
In 2010, the European Working Group on Sarcopenia in Older People 
(EWGSOP) (3) proposed a definition of sarcopenia recommending the use of the 
presence of both low muscle mass and low muscle function (strength or 
performance) for the diagnosis of sarcopenia. Thus, according to this consensus, 
diagnosis of sarcopenia requires the documentation of low muscle mass plus 
documentation of either low muscle strength or low physical performance (3). 
Muscle strength was found to be relevant as a novel sarcopenia diagnosis 
parameter because it does not depend merely on muscle mass (4) and, 
consequently, the diagnosis of sarcopenia based on muscle mass could be of 
limited clinical value (3). Therefore, an operational definition with consensus 
diagnostic criteria for sarcopenia was reported by the EWGSOP, which provided a 
working definition of sarcopenia as “a syndrome characterized by progressive and 
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generalized loss of skeletal muscle mass and strength with risk of adverse outcomes 
such as physical disability, poor quality of life and death” (3). Previously, in 2009, 
there was a similar but more restricted approach, released by the International 
Working Group on Sarcopenia (5), who provided a definition of sarcopenia as “age-
associated loss of skeletal muscle mass and function”, with the diagnosis based on 
a low whole-body or appendicular fat-free mass in combination with poor physical 
function. 
 
1.2. Prevalence 
 
Sarcopenia is estimated to occur in between 1 to 29% of community dwelling 
older adults and 14 to 33% of older adults in long-term care (6). There is less 
evidence regarding the prevalence of sarcopenia in the hospital setting. However, 
the available information suggests a prevalence of sarcopenia among hospitalized 
older patients ranging from 10 to 25.3% (7-10), as these values depend on the 
diagnostic criteria and methodology used in the different studies. 
Moreover, although sarcopenia is mainly associated with older ages and is 
considered as a geriatric syndrome, this condition can also be present in younger 
adults, especially when associated with illnesses such as dementia and 
osteoporosis (3). A study from 2013 (11) reported the presence of sarcopenia among 
healthy community dwelling individuals aged over 45 years, describing a prevalence 
of 9% in the individuals aged between 45 and 54 years and 13.5% in those aged 55 
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to 64 years. Nevertheless, the burden of sarcopenia among hospitalized younger 
adults remains to be documented. 
1.3. Etiology 
 There are several factors associated with the development of sarcopenia as 
this condition is a complex phenomenon (3, 5, 12). The main causes include genetic 
heritability (13-15), nutritional status (low protein intake, low energy intake and low 
vitamin D status) (16-21), low physical activity (22-25), hormonal changes, namely a 
decline in serum testosterone and growth hormone (26, 27), insulin resistance (28-30), 
atherosclerosis (31-33) and changes in circulating pro-inflammatory cytokines (34). 
 Figure 1 summarizes factors which have been associated with the etiology of 
sarcopenia. 
 
 
 
 
 
 
 
Sarcopenia
Neuro-
degenerative 
diseases
motor neuron loss
Disuse
immobility
physical inactivity 
Endocrine
corticosteroids, 
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sex hormones
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dysfunction
Inadequate 
nutrition / 
malabsorption
Cachexia
Figure 1 – Mechanisms of sarcopenia. Adapted from: Cruz-Jentoft et al. Age and Ageing 
2010; 39: 412–423. 
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As sarcopenia presents different possible causes, the theoretical 
categorization may be useful for clinical practice (3). Therefore, according to the 
consensus from the EWGSOP (3), sarcopenia can be categorized into primary, or 
age-related, when there is no other evident cause but ageing and secondary, when 
one or more causes can be identified. Thus, besides primary or age related, 
sarcopenia can also be activity related (ex: bed rest), disease related (ex: organ 
failure, inflammatory disease) or nutrition related (ex: malabsorption). 
The conceptual stages of sarcopenia were also described in order to facilitate 
clinical approach (3). As a result, an individual can be presarcopenic, sarcopenic or 
severely sarcopenic, depending on the severity of the condition. Table 1 
summarizes this categorization. 
 
 
 
 
 
 
Table 1 – Conceptual stages of sarcopenia. Adapted from: Cruz-Jentoft et al. Age and 
Ageing 2010; 39: 412–423. 
  
Stage Muscle Mass Muscle strength Performance 
Presarcopenia ↓   
Sarcopenia ↓  ↓     Or ↓ 
Severe sarcopenia ↓ ↓ ↓ 
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1.3.1. Sarcopenia versus cachexia 
 
 Cachexia is a complex metabolic syndrome associated with an underlying 
disease (35), such as cancer, congestive cardiomyopathy and end-stage renal 
disease (36). Moreover, the loss of muscle mass, with or without loss of fat mass, is 
related to this condition (35). Cachexia is often associated with inflammation, insulin 
resistance, anorexia, and increased protein catabolism (37).  
 Inflammation is, therefore, the key factor, and weight loss is the main 
symptom. Most cachectic individuals are also sarcopenic (38). However, not all 
sarcopenic individuals could be considered cachectic. Cachexia occurs in 
individuals of any age and it is considered as an accelerated primary model of 
sarcopenia (39). 
In a clinical perspective, it is important to distinguish sarcopenia from 
cachexia and starvation, because all these conditions cause loss of skeletal muscle 
mass and strength (40), however starvation readily reacts to nutrition support, 
whereas cachexia and sarcopenia can be refractory to nutritional interventions (36).. 
 
1.3.2. Sarcopenia versus frailty 
 
Frailty is defined as a geriatric syndrome resulting from cumulative declines 
across multiple systems and is associated with impaired homeostatic reserve and a 
reduced ability to withstand stress (41, 42). Therefore, this condition is related to 
increasing vulnerability to adverse outcomes such as falls and mortality (41, 42). 
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Unintended weight loss, exhaustion, weakness, slow gait speed and low physical 
activity are the features that support a frailty diagnosis (42). 
Frailty and sarcopenia overlap as most frail older individuals are sarcopenic, 
and there are older people with sarcopenia who are also frail (3). Notwithstanding 
this, the concept of frailty goes beyond physical factors and includes also 
psychological and social dimensions such as cognitive status, social support and 
other environmental factors (41). 
 
1.3.3. Sarcopenic obesity 
 
 The co-occurrence of sarcopenia with increased fat mass is defined as 
sarcopenic obesity, which may carry the cumulative risk derived from each of the 
two conditions (43, 44). Excess adiposity on its own may generate significant adverse 
health effects such as hypertension, dyslipidaemia and insulin resistance and there 
is increasing evidence showing that these risks can be elevated by the addition of 
low muscle mass (45).  
Sarcopenic obesity is often observed in malignancy, rheumatoid arthritis and 
ageing as in this conditions lean body mass is lost while fat mass may be preserved 
or even increased (46). Sarcopenic obesity has been associated with aggravation on 
mobility dysfunction, higher dependence in activities of daily living among 
community dwelling individuals and with higher risk of co-morbidities in hospitalized 
patients (45). The association between age-related reduction of muscle mass and 
strength is, in most cases, independent of body mass (47). It had long been described 
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that age-related loss of weight, along with muscle mass, was the main responsible 
for muscle weakness in older individuals (47). However, it is now clear that muscle 
composition has influence on muscle quality and function, as the infiltration of fat 
into muscle, also known as “marbling”, lowers its quality and performance (48). 
 
1.3.4. Sarcopenia and associated factors 
 
Several factors have been described to be associated with the presence of 
sarcopenia among hospitalized  and also community dwelling older adults older  
adults, such as age (49), schooling years (50), smoking (49)  and physical activity (11), 
BMI (11), hormonal factors (50) and hospitalization at a medical ward. Notwithstanding 
this, according to current knowledge, data on factors associated with sarcopenia 
among hospitalized younger patients, aged 18 to 64 years, are non-existent and 
remain to be documented. The research for factors associated with the presence of 
sarcopenia is of major importance, as it may allow for the recognition of modifiable 
risk factors. Since modifiable factors are identified, it will be possible to act on 
prevention. 
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1.4. Diagnosis 
1.4.1. Methodology 
 
 Muscle mass, strength and physical performance are the variables to assess 
in order to identify sarcopenia according to the EWGSOP (3). It is important to use 
the most accurate method to evaluate these variables. However, the EWGSOP (3) 
proposes different possible techniques, considering their characteristics and 
suitability for use either in research or clinical practice. 
 For muscle mass assessment, imaging techniques, such as computed 
tomography (CT) scans and magnetic resonance imaging (MRI), are very precise 
and are able to distinguish fat from other soft tissues, features that make these 
methods gold standards for estimating muscle mass (3). However, high financial 
costs and radiation exposure limits the use of these whole-body imaging methods 
in clinical practice (51). Dual energy X-ray absorptiometry (DXA) is considered the 
preferred alternative method for research and clinical practice. Nevertheless, lack 
of portability may be a limitation for clinical use (51). 
Bioelectrical impedance analysis (BIA) is an economic, easy to use, 
reproducible technique which used under standard conditions have been found to 
correlate well with MRI predictions (52). Therefore, this technique is considered a 
valid alternative to DXA (3). 
Other muscle mass estimation methods include anthropometric measures 
such as mid-arm circumference and skinfold thickness. However, changes in 
adiposity that occur with ageing and the decline of skin elasticity contribute to errors 
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of estimation in older people, making anthropometric measures vulnerable to error 
(53). The EWGSOP does not recommend anthropometry for routine use in the 
diagnosis of sarcopenia (3).  
Considering muscle strength evaluation, handgrip strength is considered the 
best and most suitable technique. This measurement has been strongly associated 
with lower extremity muscle power, knee extension, calf cross-sectional muscle area 
and is also a clinical marker of mobility (54). 
For physical performance, the Short Physical Performance Battery (SPPB), 
a combined method for assessing physical performance is referred as a standard 
measure (3). This method evaluates balance, gait speed, strength and endurance 
(55). Gait speed, which is a part of the SPPB, can also be applied as a single test (3). 
Timed get-up-and-go (TGUG) test which measures the time needed to complete a 
series of functional task and evaluates balance is another possible examination of 
performance (56, 57). 
 
1.4.2. Definition of cut-offs for diagnostic measurements 
 
 Cut-off points depend on the selected technique and the lack of reference 
studies limits value standardization. Therefore, the European consensus proposes 
various cut-off points for each recommended method or technique based on the 
information available, considering the assessment of muscle mass using DXA and 
BIA, muscle strength (by handgrip strength) or physical performance, assessed by 
SPPB or gait speed (3). 
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Despite the EWGSOP (3) recommendations concerning the most suitable 
methods and cut-off points, there is lack of standardization of the diagnostic 
procedures. Thus, prevalence of sarcopenia varies widely depending on the 
methodology used to diagnose this condition (58, 59).  
 
1.5. Sarcopenia amongst hospitalized patients 
1.5.1. Clinical impact 
 
Sarcopenia has been previously described as being related with poor clinical 
outcome in hospitalized patients. This condition has also been associated with 
higher mortality (7, 60), higher risk of non-elective readmission in a six month period 
(7) and worst post-operative outcomes (61-65).  
Length of hospital stay (LOS) is a widely used indicator of the changes that 
occur during a hospitalization process and can be used as a surrogate marker of 
health status (66). Thus, prediction of LOS may lead to a maximization of resources 
(67).  
Concerning the association of sarcopenia with LOS, information is scarce and 
controversial. Results from a study conducted among hospitalized patients aged 
≥65 years showed that sarcopenic patients with a mean age of 79 years had longer 
LOS than non-sarcopenic patients (7). In contrast, no differences in LOS between 
sarcopenic and non-sarcopenic older patients with a mean age of 84.2 years were 
reported by Cerri et al. (9). Moreover, a study conducted among cancer patients, with 
sarcopenia defined through computed tomography scans, reported sarcopenic 
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patients to present longer LOS than non-sarcopenic patients (39 days versus 30 
days, p<0.001) (61). 
The establishment of an association between sarcopenia and LOS is, 
therefore, of utmost importance in order to provide a more effective healthcare plan 
and reduce adverse consequences. 
The potential effect of confounding factors on the association between 
sarcopenia and LOS remains to be described, as well as the quantification of the 
association of sarcopenia with LOS among a wide-ranging sample of hospitalized 
patients. Increasing the knowledge on this subject could be a major advantage for 
clinical setting, in order to provide a more effective healthcare plan and thus 
reducing the adverse consequences that sarcopenia entails. 
 
1.5.2. Financial impact 
 
 Considering the previously described impact of sarcopenia on hospitalized 
individuals, healthcare costs of this condition are expected to be high (68). 
Notwithstanding this, data on the financial burden of sarcopenia are limited. One 
study from 2004 (69), which was conducted among representative samples of 
American adults aged ≥ 60 years, reported that the estimated healthcare cost 
attributable to sarcopenia defined merely as the loss of muscle mass was $18.5 
billion, being $10.8 billion in men and $7.7 billion in women. Nevertheless, although 
sarcopenia has been previously associated to higher hospitalization costs, this 
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information is still limited to surgical patients (70-72). Thus, the impact of sarcopenia 
on hospitalization costs among a wider group of patients remains to be documented. 
Considering the adverse consequences sarcopenia entails among 
hospitalized patients and the financial constraints that healthcare systems often 
face, in order to maximize resources and provide a more effective healthcare plan, 
it is important to recognize and to explore the association of sarcopenia with 
hospitalization costs. 
 
2. Anthropometry and body composition assessment 
 
Anthropometry, from the Greek anthropos, man, and metron, measure, is 
defined as a measure to study human body dimensions and has been used since 
ancient times (73, 74). This method was originally used, not for science but for artistic 
purpose: painters and sculptors needed information about human body constitution 
so that they could make authentic representations (75).  
 Anthropometry was firstly applied for epidemiological studies, specifically for 
nutritional assessment and its association with clinical outcomes, in the second half 
of the twentieth century (76). Anthropometric measures provide useful information on 
body composition assessment and the techniques used are non-invasive, economic 
and easy-to-use both for clinical practice and research purposes (77-79). 
These measures are of utmost importance in nutrition risk screening and 
assessment, particularly in hospital settings, as undernutrition is an important 
predictor of poor prognosis and longer length of hospital stay (80, 81). 
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Anthropometric measures are not currently recommended by the EWGSOP 
as a method for sarcopenia diagnosis. However, as mentioned above, besides 
being universally used, anthropometry is often the only available method for 
professionals to evaluate body composition and nutrition status in clinical settings. 
Therefore, even though anthropometric measures are not considered by this 
European Consensus as being suitable for routine use in clinical practice, they still 
are amongst the most relevant methods for body composition assessment. Thus, 
concerning the identification of sarcopenia, anthropometric measurements can still 
be applied for screening purposes and, therefore, be used as complimentary 
methods to the recommended techniques. 
Body circumferences and skinfold thickness are amongst the most widely 
used measures, both for research and clinical practice, due to their predictive value 
and association with a variety of conditions, in addition to their usefulness for 
predicting other relevant anthropometric measurements, such as weight and height 
when their measurement is impossible to obtain. 
 
2.1. Assessment of body circumferences: the effect of posture and body 
complexion 
 
 For the assessment of body circumferences, protocols currently used (82) 
indicate supine position as the correct position for performing measurements. 
However, especially in hospital settings, individuals are often unable to change their 
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body position (83, 84). For instance, to evaluate a critical patient or a bedridden patient, 
it is necessary to adapt the standard procedure to the body position. 
 Body circumference results, namely arm, waist, hip and calf girths, are 
frequently used for body composition and nutritional assessment purposes, isolated 
or as part of undernutrition diagnosis and screening tools (85, 86). The effect of posture 
on body circumferences assessment could be of major relevance as it can 
compromise the entire body composition assessment results. 
 Previous reports had shown that body posture influenced anthropometric 
measurements of the lower limbs in young free-living adults (83) and, more recently, 
a study conducted among institutionalized and hospitalized older adults aged ≥65 
years (87) showed that differences between body circumferences measurements 
obtained on standing and supine positions did not have clinically relevant impact on 
nutritional assessment. However, it is not known if age-related differences in body 
composition can change these results when younger hospitalized individuals are 
assessed. Nevertheless, information on the effect of posture on body 
circumferences in hospitalized younger adult patients aged < 65 years, is still 
lacking. 
 Besides posture, factors such as physical complexion are also susceptible of 
introducing bias in body circumferences assessment. Anthropometric 
measurements in obese (or overweight) patients, due to the presence of a larger 
body size are more susceptible to error, even with a trained anthropometrist. Thus, 
it not currently known if posture related changes differ when measurements are 
evaluated in overweight or obese subjects rather than in individuals with normal 
weight. This possible influence of overweight or obesity in body circumferences 
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assessment needs to be documented, as, in clinical practice, this effect can lead to 
a misinterpretation of anthropometry and, consequently, a misclassification of 
nutritional status assessment. 
 
2.2. Skinfold thickness measurement: the effect of compressibility 
 
Skinfold thickness data allows for inference on body composition (88). This is 
a substantially used measurement for monitoring subcutaneous adiposity due to its 
accessibility and non-invasive nature (89). Moreover, this measurement can be used 
to predict adiposity and it is integrated, along with mid-arm circumference, in mid-
arm muscle circumference formula, through which it is possible to estimate muscle 
mass (76). 
In skinfold thickness measurement using a skinfold calliper, a constant 
pressure is applied for two seconds (82). Tissue’s dynamic response to this pressure 
is defined as compressibility and it has been studied using coarse methods based 
on the comparison between skinfold calliper measurements and subcutaneous fat 
thickness assessed by imaging methods or cadaver studies (88, 90). 
Moreover, there are assumptions that underlie the estimation of body fatness, 
based on skinfold thickness measure: skin thickness is negligible, adipose tissue 
has constant characteristics and also that proportion of subcutaneous to visceral fat 
is equivalent in all subjects (88). However, based on the previous studies using 
empiric comparisons and cadaver studies (89-91), it has been shown that 
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compressibility varies according to the body part where measurement is performed 
and also between individuals. 
Some individual characteristics have been described as being associated 
with compressibility, namely the site of measurement (92), gender (90), age (93), skin 
thickness (94), hydration status (93) and subcutaneous tissue pressure (94). This 
variability affects the relation between the measurement and the actual adipose 
thickness, introducing error in the estimation of body fatness (88, 90). Over the past 
few years, knowledge on compressibility has not significantly increased and up-to-
date information on this subject is scarce. 
Recently, a new skinfold calliper was developed, the Lipotool® (Fig.2) (95). This 
calliper is automatic and acquires sixty measurements per second, firstly allowing 
for documenting tissue’s dynamic response to a constant pressure of 10 g/mm2. 
Thus, it will firstly enable to identify factors related to skinfold compressibility (95). 
 
 
 
 
 
 
 
Considering the wide use of skinfold thickness, the recognition of skinfold 
thickness compressibility is of utmost importance, as it may allow to control for the 
differences of the compressibility on the measurements and its interpretation. Thus, 
Figure 2 – Lipotool® skinfold calliper 
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reducing bias would be advantageous in order to provide a more valid use of 
anthropometry. 
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Aims 
 
The present work aims to: 
 
1. Increase the knowledge about sarcopenia among hospitalized patients 
(Chapter I) 
1.1. Evaluate the frequency of sarcopenia among hospitalized 
patients and study the impact of different diagnostic criteria on 
sarcopenia diagnosis (Chapter I.a). 
1.2. Identify factors associated with sarcopenia and increase the 
knowledge about clinical (Chapter I.b) and financial impact 
(Chapter I.c) of sarcopenia among hospitalized patients. 
 
2. Explore potential sources of error in the assessment of body circumferences 
and skinfold thickness (Chapter II): 
2.1. Quantify the effect of posture on body circumferences among 
adults and older adults, associated with body mass index 
(Chapter IIa). 
2.2. Describe and explore differences between several individual 
characteristics in the compressibility of triceps skinfold and 
factors associated with compressibility (Chapter IIb). 
 
 
  
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
25 
 
 
 
 
 
Chapter I 
 
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF 
Sarcopenia among hospitalized patients – A cross-sectional study 
Clin Nutr. 2014 [published online] 
 
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF 
Sarcopenia and length of hospital stay 
Under review 
 
Sousa AS, Guerra RS, Fonseca I, Pichel F, Ferreira S, Amaral TF 
Financial impact of sarcopenia on hospitalization costs 
Under review 
 
 
 
  
 26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
27 
 
 
 
 
 
 
Chapter I.a 
 
Sarcopenia among hospitalized patients 
– A cross-sectional study 
  
  
  
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
29 
 
 
  
30 
 
 
  
31 
 
 
  
32 
 
 
  
33 
 
 
  
34 
 
 
  
35 
 
 
 
 
 
Chapter I.b 
Sarcopenia and length of hospital stay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
37 
 
Sarcopenia and length of hospital stay 
 
Ana S. Sousa1, Rita S. Guerra2,3, Isabel Fonseca4, Fernando Pichel4, Teresa F. 
Amaral1,3 
1 Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto, 
Porto, Portugal 
Rua Dr. Roberto Frias, 4200-465 Porto, Portugal 
2 Departamento de Bioquímica da Faculdade de Medicina, Universidade do 
Porto, Porto, Portugal  
Al. Prof. Hernâni Monteiro, 4200 - 319 Porto, Portugal 
3 UISPA-INEGI, Faculdade de Engenharia, Universidade do Porto, Porto, 
Portugal 
Rua Dr. Roberto Frias, 4200-465 Porto, Portugal 
4 Serviço de Nutrição e Alimentação, Centro Hospitalar do Porto, Porto, Portugal 
Largo Prof. Abel Salazar, 4099-001 Porto, Portugal 
 
 
Acknowledgements 
R. S. G. received a scholarship from Fundação para a Ciência e a Tecnologia, 
financing program POPH/FSE, under the project SFRH/BD/61656/2009. 
The authors declare no conflicts of interest. 
 
 
  
38 
 
Abstract 
Background/Objectives: We aimed to quantify the association of sarcopenia with 
length of hospital stay (LOS) and to identify factors associated with sarcopenia 
among hospitalized patients.  
Subjects/Methods: 655 patients composed the study sample. A longitudinal study 
was conducted in a university hospital. Sarcopenia was defined, according to 
European Consensus criteria, as low muscle mass (bioelectrical impedance 
analysis) and low muscle function (handgrip strength). Logistic regression, Kaplan-
Meier and Cox adjusted proportional hazards methods were used. LOS was 
determined from the date of hospital admission and discharge home (event of 
interest).  
Results: Participants were aged 18 to 90 years (24.3% sarcopenic). Factors 
associated with sarcopenia were male gender, age ≥65 years, moderate or severe 
dependence, undernutrition and being admitted to a medical ward. Sarcopenic 
patients presented a lower probability of being discharged home (Hazard Ratio 
(HR), 95% Confidence Interval (CI) = 0.71, 0.58-0.86). However, after stratifying for 
age groups, this effect was visible only in patients aged <65 years (HR, 95% CI= 
0.66, 0.51-0.86). Moreover, sarcopenic overweight or obese patients presented a 
higher probability of being discharged home (HR, 95% CI = 0.78, 0.61-0.99) than 
non-overweight sarcopenic patients (HR, 95% CI = 0.63, 0.48-0-83).  
Conclusions: Being male, aged ≥65 years, presenting dependence, being 
undernourished and admitted to a medical ward were factors associated with 
sarcopenia among hospitalized adult patients. Sarcopenia is independently 
associated with longer LOS, although this association is stronger for patients aged 
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<65 years. Moreover, sarcopenic overweight was associated with a higher 
probability of discharge home than non-overweight sarcopenia. 
 
Key-words: sarcopenia; handgrip strength; hospital; survival analysis; length of 
stay 
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Introduction 
According to the European Working Group on Sarcopenia in Older People 
(EWGSOP) sarcopenia is defined as a combination of both low muscle mass and 
low muscle function (1). This condition has been associated with physical disability, 
low quality of life and higher mortality (1, 2).  
Sarcopenia is estimated to occur between 5 to 45% of community dwelling 
older adults (3-5). While this condition is mainly observed in older adults, it can also 
be present in younger individuals. A study from 2013 by Cherin et al. (6) showed that 
9% of the individuals aged between 45 and 54 years and 13.5% of those aged from 
55 to 64 years were sarcopenic. Although data concerning sarcopenia in 
hospitalized patients are scarce, previous studies have described this condition as 
frequent among hospitalized older patients (7-11), ranging from 10% to 37.3%. 
Moreover, it has been recently shown that sarcopenia is present in hospitalized 
patients aged under 65 years, with a frequency equal to 19.8% (10). 
It has been previously reported that sarcopenia is related with poor clinical 
outcome in hospitalized older patients, namely higher mortality (7, 9, 12), higher risk of 
non-elective readmission in a six month period (7) and worst post-operative 
outcomes (13-16).  
In a study conducted among hospitalized patients aged ≥65 years (7), 
sarcopenic patients presenting a mean age of 79 years were reported to have higher 
length of hospital stay (LOS) than non-sarcopenic patients. In contrast, Cerri et al. 
(2014) (9) found no differences in LOS between sarcopenic and non-sarcopenic 
patients, among hospitalized older patients, with a mean age of 84.2 years, ranging 
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from 66 to 100 years. Nevertheless, as far as we are concerned, there are no 
available data on the impact of sarcopenia on LOS among hospitalized patients 
aged <65 years. LOS is an indicator of the changes that occur during a 
hospitalization process and can be used as a surrogate marker of health status (17). 
Moreover, predicting LOS may lead to a maximization of resources (18).  
According to our knowledge, data on factors associated with sarcopenia in 
hospitalized patients are scarce while it is particularly limited among hospitalized 
younger patients. Moreover, the potential effect of confounding factors on the 
association between sarcopenia and LOS remains to be described. Identification of 
sarcopenia and the establishment of an association between this condition and LOS 
are of utmost importance in order to provide a more effective healthcare plan and 
thus reducing the adverse consequences this condition entails. 
This study aims to quantify the association of sarcopenia with LOS, after 
adjustment for potential confounders and to identify factors associated with 
sarcopenia among a wide-ranging sample of hospitalized adult patients. 
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Materials and Methods 
Study sample and design 
A longitudinal study was conducted in a general, university and 600 beds 
hospital between July 2011 and December 2014. A consecutive sampling method 
was applied in medical and surgical wards. Patients were eligible to participate in 
the study if they were aged 18 years and over, Caucasian, with an expected hospital 
stay longer than 24 hours, conscious, cooperative and capable of providing written 
informed consent. 
Patients unable to perform the handgrip strength (HGS) technique were 
excluded from the study. This impossibility in carrying out HGS measurement was 
defined as an inability to understand verbal instructions or having a condition limiting 
HGS measurement (namely pain). Critically ill patients, i.e., with a life-threatening 
medical or surgical condition requiring intensive care unit level care, presenting 
severe organ system dysfunction and needing for active therapeutic support were 
excluded (19). Pregnancy and patient ward isolation were also defined as exclusion 
criteria. According to these criteria, patients admitted to neurology, clinical 
haematology and intensive care unit wards were not recruited whereas participants 
from the following departments were selected: angiology and vascular surgery, 
cardiology, digestive surgery, endocrinology, gastroenterology, hepatobiliary 
surgery, internal medicine, nephrology, non-digestive surgery, orthopaedics, 
otorhinolaryngology and urology. Therefore, from the daily list of inpatients admitted 
to each of these wards, those who fulfilled inclusion criteria were invited to 
participate in the study, until the number of patients had attained the total number 
of beds of the ward. 
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From 992 patients who fulfilled the inclusion criteria and were invited to 
participate, 337 (34%) were not included. The reasons were refusals (n=198), 
cognitive impairment (n=13) and missing data (n=126). 
All patients were followed up from the time of admission until death, hospital 
discharge or 30 days after admission. 
 
Ethics  
This research was carried out according to the recommendations established 
by the Declaration of Helsinki and approved by the Institutional ethics and review 
boards of Centro Hospitalar do Porto. All study participants provided a written 
informed consent. 
 
Data collection 
Demographical, clinical data, medical diagnoses and data of hospital 
admission were retrieved from patient's clinical file at the time of evaluation. Date of 
hospital discharge, discharge destination (home, another ward, another hospital, 
continuing care unit and discharge against medical advice or death) and discharge 
diagnosis were retrieved from hospital records after patient discharge. All other 
information was obtained by two trained registered nutritionists through a structured 
questionnaire within 72h of admission to hospital. 
Education was evaluated by the number of completed school years and the 
following categories were created: 0-4, 5-12 and more than 12 years. Marital status 
was categorized as single, married or in a civil partnership, divorced and widowed. 
Cognitive impairment was evaluated with the Abbreviated Mental Test (AMT) (20). 
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Independence in activities of daily living was assessed with the Katz index (21). 
Charlson disease severity index (22) was obtained by two previously trained 
interviewers using medical discharge diagnoses in the patient's clinical record. 
Patient nutritional status was evaluated with Patient - Generated Subjective 
Global Assessment (PG-SGA) (23). Standing height (cm) was measured with a metal 
tape (Rosscraft, Innovations Incorporated, Surrey, Canada) with a 0.1 cm resolution 
and a headboard. Body weight (kg) was assessed with a calibrated portable beam 
scale with a 0.5 kg resolution. All anthropometric measurements were performed by 
two previously trained registered nutritionists using standard methods (24). The intra- 
and inter- observer technical error of measurement was calculated for all 
measurements, respectively, in 17 and 18 individuals. Intra-observer ranged from 
0.2% to 0.6%, and inter-observer error ranged from 0 to 1.4%. These values are 
considered acceptable for trained anthropometrists (25). 
Body mass index (BMI) was determined through the standard formula [weight 
(kg) / height2 (m)] and BMI categories were created according to the World Health 
Organization cut-offs (26). 
Sarcopenia was defined according to the EWGSOP as the presence of both 
low muscle mass and low muscle function (1). 
Whole body resistance (ohms) and reactance (ohms) were assessed through 
tetrapolar bioelectrical impedance analysis (BIA) using a Biodynamics Model 450 
(Seattle, Washington USA) with 0.1 ohm resolution, operating at a single frequency 
of 50 KHz.  
Muscle mass was evaluated using the equation of Janssen et al. (2000) (27): 
[(height2/ resistance × 0.401) + (gender × 3.825) + (age × –0.071)] + 5.102, with 
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height measured in cm; resistance measured in ohms; for gender, men = 1 and 
women = 0; age measured in years. Muscle mass was adjusted for height. Gender 
specific cut-off points indicated in the EWGSOP consensus were used (1). 
Muscle function was evaluated as HGS, using a calibrated Jamar® Hydraulic 
Hand dynamometer (Sammons Preston, Bolingbrook, IL, USA), with a 0.1 kgf 
resolution. The Jamar® dynamometer is proposed by the American Society of Hand 
Therapists as the gold standard for measurements of HGS (28). Each subject 
undertook three measurements using the non-dominant hand with a one minute 
interval between measurements and the maximum value was selected (29). Low 
HGS was classified using the cut-offs proposed in the EWGSOP Consensus (1): less 
than 30 kgf for men and 20 kgf for women. 
 
Statistics 
According to the normality of variables distribution, evaluated through 
Kolmogorov-Smirnov test, results were described as mean and standard deviation 
or as median and interquartile range (IQR) if non-normal distribution. Categorical 
variables were reported as frequencies. 
In order to identify variables associated with sarcopenia by bivariable 
analysis, sarcopenic and non-sarcopenic patients were compared for several 
demographic and clinical characteristics. Bivariable and multivariable logistic 
regression models were also conducted. Variables were included in the 
multivariable logistic regression model considering their potential confounding 
effect. Length of hospital stay was dichotomized according to a cut-off of 7 days 
based on the median LOS of the entire sample, and in agreement with the median 
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LOS in Portuguese hospitals (30). Variables associated with longer LOS (≥7 days) 
were identified comparing patients with and without a long LOS. All the comparisons 
were computed using Mann-Whitney test, or Student’s t test for independent 
samples, for continuous variables and Pearson χ2 or Fisher’s exact test for 
categorical variables. 
Length of hospital stay was determined from the date of hospital admission 
and discharge to usual residence (the main event of interest). Patients who were 
not discharged from the hospital to usual residence within the study period were 
censored at the time of other events, namely death, transfer (to another hospital 
ward, to another hospital or to continuing care units) and discharge against medical 
advice (n=40). Length of hospital stay was censored at 30 days, so patients that 
remained hospitalized 30 days after hospital admission were also censored (n=16). 
The Kaplan-Meier method was used to estimate the cumulative probability of being 
discharge-free over time (i.e. to experience the event of interest, defined as 
discharge home within the follow-up interval), according to the presence or the 
absence of sarcopenia. 
Multivariable Cox proportional hazards regression models were used to 
estimate adjusted hazard ratios (HR) and corresponding 95% confidence intervals 
(CI). The following characteristics were considered in the multivariable procedure: 
presence of sarcopenia (categorical), age (categorical), Charlson index 
(continuous), nutritional status categories according to PG-SGA (categorical), 
education (categorical), Katz index (categorical), gender (categorical), marital status 
(categorical) and AMT (continuous).  
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Statistical significance was set at p < 0.05. All analyses were conducted with 
the Software Package for Social Sciences (SPSS) for Windows (version 20.0; 
SPSS, Inc., Chicago, IL). 
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Results 
Baseline characteristics of the 655 hospitalized patients enrolled in this study, 
according to sarcopenia status are shown in Table 1. Approximately half of patients 
were women (46.1%), age ranged between 18 and 90 years old (median (IQR) = 56 
(22) years). Frequency of sarcopenia was 24.3%. Within the period the present 
study was conducted two patients had died. Therefore, mortality rate was 0.3%. 
Sarcopenic patients were older and presented longer LOS than non-
sarcopenic patients (Table 1). Also, they were more likely to be male, to be 
undernourished and to present higher Charlson index score than non-sarcopenic 
patients (Table 1). There was a higher proportion of sarcopenic patients in medical 
wards than in surgical wards. The highest proportion of sarcopenic patients (34.3%) 
was observed in internal medicine wards. Otorhinolaryngology presented the lowest 
proportion of sarcopenic patients (1.9%). 
It is worth noticing that patients aged ≥ 65 years presented lower muscle 
mass (median (IQR) 24.8 (11.4) kg) than patients aged < 65 years (median (IQR) 
26.4 (11.4) kg), p= 0.008. Older patients also presented lower HGS than patients 
aged<65 years (median (IQR) 22.0 (9.8) kgf versus median (IQR) 24.1 (17.5) kgf), 
p<0.001. 
As shown in Table 2, after adjusting for potential confounders, being a male, 
aged ≥65 years, presenting moderate or severe dependence, being undernourished 
and being admitted to a medical ward were factors associated with sarcopenia.  
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Table 1 – Participants’ baseline characteristics according to sarcopenia status. 
  
Non-sarcopenic 
(n=496) 
 
Sarcopenic 
(n=159) 
p 
    
Age (years), median (IQR) 54 (24.0) 64 (19.0) <0.001 2 
Age categories, n (%) 
   < 65 
   ≥ 65 
 
367 (74.0) 
129 (26.0) 
 
85 (53.5) 
74 (46.5) 
 
 
<0.001 1 
Gender, n (%) 
Women 
Men 
 
244 (49.2) 
252 (50.8) 
 
58 (36.5) 
101 (63.5) 
 
 
0.006 1 
Education (years), n (%) 
0-4 
5-12 
>12 
 
183 (36.9) 
270 (54.4) 
43 (8.7) 
 
81 (50.9) 
64 (40.3) 
14 (8.8) 
 
0.005 1 
Marital status, n (%) 
Single 
Non-single 
 
91 (18.3) 
405 (81.7) 
 
25 (15.7) 
134 (84.3) 
 
 
0.477 1 
AMT, median (IQR) 10.0 (1.0) 10.0 (1.0) 0.437 2 
Charlson Index, median (IQR) 1.0 (2.0) 2.0 (3.0) 0.002 2 
PG-SGA, n (%) 
Non-undernourished 
Undernourished 
 
298 (60.1) 
198 (39.9) 
 
63 (39.6) 
96 (60.4) 
 
<0.001 1 
Table continued  
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Non-sarcopenic 
(n=496) 
 
Sarcopenic 
(n=159) 
p 
Katz index, n (%) 
Independent 
Moderate / severe dependence 
 
481 (97.0) 
15 (3.0) 
 
143 (89.9) 
16 (10.1) 
 
0.001 1 
BMI categories, n (%) 
Underweight 
Normal weight 
Overweight /obesity 
 
11 (2.2) 
207 (41.7) 
278 (56.0) 
 
8 (5.0) 
62 (39.0) 
89 (56.0) 
 
0.1731 
Hospital ward, n (%) 
   Medical 
   Surgical 
 
223 (45.0) 
273 (55.0) 
 
96 (60.4) 
63 (39.6) 
 
 
0.001 1 
LOS, days, median (IQR) 6.0 (6.0) 9.0 (10.0) <0.001 2 
LOS, days, n (%) 
<7 
 ≥7 
 
251 (50.6) 
245 (49.4) 
 
55 (34.6) 
104 (65.4) 
 
 
<0.001 1 
HGS (kgf), median (IQR) 
   Women 
   Men 
 
18.0 (9.4) 
35.4 (8.0) 
 
13.0 (6.5) 
23.4 (7.2) 
 
<0.001 2 
<0.001 2 
Muscle Mass (kg), median (IQR) 26.2 (11.8) 24.9 (6.7) 0.002 2 
 
 IQR, Interquartile range;  AMT, Abbreviated Mental Test; PG-SGA, Patient-Generated Subjective Global Assessment;  
 BMI, body mass index; LOS, length of hospital stay; HGS, handgrip strength. 
1 Chi-square test or Fisher’s Exact test; 2 Mann-Whitney test; 
Table 1 continued  
  
51 
 
Table 2 - Factors associated with sarcopenia using a bivariable and a multivariable 
logistic regression model. 
 
OR, Odds Ratio; CI, confidence interval;  
PG-SGA, Patient-Generated Subjective Global Assessment; BMI, body mass index; LOS, length of hospital 
stay 
 
  
Crude 
OR (95%CI) 
 
p 
 
Adjusted 
OR (95%CI) 
 
p 
     
Age categories, n (%) 
   < 65 
   ≥ 65 
 
1 
2.48 (1.71-2.44) 
 
 
<0.001 
 
1 
2.01 (1.34-3.02) 
 
 
0.001 
Gender, n (%) 
Women 
Men 
 
1 
1.69 (1.17-2.44) 
 
 
0.005 
 
1 
1.83 (1.22-2.72) 
 
 
0.003 
Education (years), n (%) 
0-4 
5-12 
>12 
 
1.36 (0.70-2.62) 
0.73 (0.38-1.41) 
1 
 
0.360 
0.347 
 
1.23 (0.60-2.55) 
0.75 (0.36-1.56) 
1 
 
0.573 
0.447 
Marital status, n (%) 
Single 
Non-single 
 
1 
1.20 (0.74-1.95) 
 
 
0.451 
 
1 
1.23 (0.72-2.12) 
 
 
0.453 
PG-SGA, n (%) 
   Non-undernourished 
   Undernourished 
 
1 
2.29 (1.59-3.30) 
 
 
<0.001 
 
1 
1.74 (1.16-2.60) 
 
 
0.008 
Katz index, n (%) 
Independent 
   Dependent 
 
1 
3.59 (1.73-7.44) 
 
 
0.001 
 
1 
2.50 (1.14-5.46) 
 
 
 
0.022 
BMI categories, n (%) 
   Underweight 
   Normal weight 
   Overweight /obesity 
 
1.07 (0.74-1.55) 
1 
2.43 (0.94-6.30) 
 
0.725 
 
0.068 
 
1.18 (0.78-1.79) 
1 
2.00 (0.72-5.61) 
 
0.429 
 
0.184 
Hospital ward, n (%) 
   Medical 
   Surgical 
 
1.86 (1.30-2.68) 
1 
 
0.001 
 
1.74 (1.18-2.56) 
1 
 
0.005 
LOS, days, n (%) 
   <7 
   ≥7 
 
1 
1.94 (1.34-2.81) 
 
 
<0.001 
 
1 
1.47 (0.98-2.22) 
 
 
0.064 
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Participants’ characteristics were also stratified according to LOS (< 7 days 
and ≥ 7 days), as presented in Table 3. Compared to patients with a short LOS, 
patients with longer hospital stay were older, had a lower education level, were less 
likely to be single, presented a lower AMT score, were more likely to be dependent 
according to Katz index, were less likely to be overweight or obese, presented 
reduced HGS, were more likely to be undernourished, sarcopenic and presented a 
higher Charlson index score. 
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Table 3 – Participants’ characteristics stratified according to length of hospital stay (LOS) 
(days). 
 
 
 
 
 
 
 
LOS < 7 
(n=306) 
 
LOS ≥ 7 
(n=349) 
p 
Gender, n (%) 
Women 
Men 
 
146 (47.7) 
160 (52.3) 
 
156 (44.7) 
193 (55.3) 
 
0.480 1 
Age, median (IQR) 53 (25.3) 59 (21.0) <0.001 2 
Education (years), n (%) 
0-4 
5-12 
>12 
 
120 (39.2) 
150 (49.0) 
36 (11.8) 
 
144 (41.3) 
184 (52.7) 
21 (6.0) 
 
0.033 1 
Marital status, n (%) 
Single 
Non-single 
 
66 (21.6) 
240 (78.4) 
 
50 (14.3) 
299 (85.7) 
 
0.018 1 
AMT, median (IQR) 10.0 (1.0) 9.0 (1.0) 0.004 2 
Katz index, n (%) 
Independent 
Moderate/Severe dependence 
 
300 (98.0) 
6 (2.0) 
 
324 (92.8) 
25 (7.2) 
 
0.002 1 
PG-SGA, n (%) 
Non-undernourished 
Undernourished 
 
214 (69.9) 
92 (30.1) 
 
147 (42.1) 
202 (57.9) 
 
<0.001 1 
Sarcopenia, n (%) 
Non-sarcopenic  
Sarcopenic 
 
251 (82.0) 
55 (18.0) 
 
245 (70.2) 
104 (29.8) 
0.002 1 
BMI categories, n (%) 
Underweight 
Normal Weight 
Overweight / obesity 
 
6 (2.0) 
117 (38.2) 
183 (59.8) 
 
13 (3.7) 
152 (43.6) 
184 (52.7) 
 
0.018 1 
HGS (kgf), median (IQR) 25.3 (14.8) 22.9 (18.0) <0.001 2 
Charlson Index, median (IQR) 1.0 (2.0) 2.0 (3.0) 0.005 2 
IQR, interquartile range;  AMT, Abbreviated Mental Test; PG-SGA, Patient-Generated Subjective Global 
Assessment;  BMI, body mass index; HGS, handgrip strength. 
 1 Chi-square test or Fisher’s Exact test; 2 Mann-Whitney test; 
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Figure 1 shows the probability of being discharge-free over time according to 
the presence of sarcopenia, considering all the participants (Figure 1A), and 
stratified by age groups, < 65 years (Figure 1B) and ≥ 65 years (Figure 1C). 
Sarcopenic patients presented a lower probability of experiencing the event of 
interest (being discharged home), as displayed in Figures 1A and 1B. However, for 
patients aged ≥ 65 years, this effect was no longer visible (Figure 1C). 
The association of sarcopenia with overweight or obesity (BMI ≥ 25 kg/m2) 
was also evaluated. From all sarcopenic patients (n=159), 44% presented only 
sarcopenia and 56% of the patients were simultaneously overweight (or obese) and 
sarcopenic. It is noteworthy that sarcopenic patients who were simultaneously 
overweight or obese presented higher muscle mass than non-overweight 
sarcopenic patients, median 25.5 (12.4) kg vs median 24.1 (9.8) kg, p<0.001, and 
also higher muscle mass adjusted for height, mean 10.1 (2.0) kg/m2 vs mean 9.1 
(1.7) kg/m2, p<0.001. Compared with non-sarcopenic patients, sarcopenic patients 
present a lower probability of being discharged home. However, patients with non-
overweight sarcopenia presented a lower probability of being discharged home 
compared with sarcopenic overweight patients (p<0.001) (Figure 1D). 
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Figure 1 - Probability of being discharge-free over time according to sarcopenia status. 
A: entire sample                     B: age < 65 years 
 
 
 
 
 
 
 
             C                                                           
                           D 
 
 
 
 
 
               
C: age ≥ 65 years                                                               D: entire sample (overweight and non- 
                                                                                                 overweight patients) 
                                                                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 p <0.001 
 p < 0.001 
 p =0.131 
p <0.001 
 p < 0.001 
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Results from multivariable Cox proportional hazards regression models were 
displayed for the entire sample and according to age groups (Table 4). The model 
was adjusted for age, gender, marital status, education, nutritional status, Charlson 
index, AMT score and Katz index, as these variables could be considered as 
potential confounders in the association between sarcopenia and LOS. 
Considering the entire sample and the group of patients aged < 65 years, 
sarcopenia was consistently associated with lower HR (<1) for being discharged 
home, meaning that sarcopenic patients presented a lower probability of being 
discharged home. However, for patients aged ≥ 65 years, sarcopenia was not 
independently associated with the probability of being discharged home. 
It is worth noticing that sarcopenic overweight or obese patients presented a 
higher probability of being discharged home, adjusted HR (95% CI) = 0.78 (0.61-
0.99) than non-overweight sarcopenic patients, adjusted HR (95% CI) = 0.63 (0.48-
0.83). 
Additionally, LOS had also been stratified according to hospital ward (medical 
or surgical) and, as expected, there was a higher proportion of patients with a longer 
LOS (≥7 days) admitted to medical wards (53%) than in surgical wards (47%), 
p=0.019. Thus, the type of hospital ward was included in an additional multivariable 
Cox proportional hazards regression model. However, the inclusion of this variable 
did not modify the results concerning the probability of being discharged home.    
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Table 4 - Hazard ratios (HR) of being discharged home associated with the presence of sarcopenia. 
 
           All patients 
            (n=655) 
        Age < 65 years 
            (n= 452) 
         Age ≥ 65 years 
            (n= 203) 
 
 
Adjusted HR (95% CI) 
 
p 
 
Adjusted HR (95% CI) 
 
p 
 
Adjusted HR (95% CI) 
 
p 
 
Sarcopenia 
  Non-sarcopenic 
  Sarcopenic 
 
 
1 
0.71 (0.58-0.86) 
 
 
 
0.001 
 
 
1 
0.66 (0.51-0.86) 
 
 
 
0.002 
 
 
1 
0.80 (0.58-1.10) 
 
 
 
0.168 
Gender 
  Female 
  Male 
 
1 
1.00 (0.85-1.19) 
 
 
0.969 
 
1 
0.97 (0.79-1.18) 
 
 
0.754 
 
1 
1.18 (0.84-1.66) 
 
 
0.328 
Age (years) 
  < 65 
  ≥ 65  
 
1 
0.94 (0.78-1.13) 
 
 
0.535 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
Education (years) 
  0-4 
  4-12 
  >12 
 
1 
0.81 (0.67-0.97) 
1.24 (0.92-1.68) 
 
 
0.023 
0.156 
 
1 
0.74 (0.59-0.93) 
1.23 (0.83-1.33) 
 
 
0.010 
0.293 
 
1 
0.82 (0.59-1.14) 
0.92 (0.56-1.53) 
 
 
0.235 
0.759 
Table continued  
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CI, confidence interval; AMT, Abbreviated Mental Test; PG-SGA, Patient-Generated Subjective Global Assessment. 
              All patients 
               (n=655) 
         Age < 65 years 
              (n= 452) 
         Age ≥ 65 years 
               (n= 203) 
 
 
Adjusted HR (95% CI) 
 
P 
 
Adjusted HR (95% CI) 
 
p 
 
Adjusted HR (95% CI) 
 
p 
 
Marital Status 
  Single 
  Non-single 
 
 
1 
0.87 (0.70-1.07) 
 
 
 
0.190 
 
 
1 
0.82 (0.64-1.03) 
 
 
 
0.094 
 
 
1 
1.22 (0.66-2.25) 
 
 
 
0.531 
AMT 1.05 (0.96-1.14) 0.301 1.10 (0.99-1.24) 0.079 0.98 (0.85-1.12) 0.733 
Katz index 
  Independent 
  Moderate / Severe dependence 
 
1 
0.77 (0.52-1.14) 
 
 
0.188 
 
1 
0.74 (0.45-1.23) 
 
 
0.250 
 
1 
0.71 (0.38-1.31) 
 
 
0.268 
PG-SGA 
  Non-undernourished 
  Moderate / Severe undernutrition 
 
1 
0.56 (0.47-0.66) 
 
 
<0.001 
 
1 
0.51 (0.41-0.62) 
 
 
<0.001 
 
1 
0.70 (0.51-0.97) 
 
 
0.030 
Charlson index 0.94 (0.90-0.98) 0.003 0.95 (0.90-1.00) 0.068 0.90 (0.83-0.98) 0.010 
Table 4 continued  
Table 3 - Hazard ratios (HR) of being discharge-free over time associated with the presence of 
sarcopenia. 
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Discussion 
The present study results show that sarcopenic patients presented a lower 
probability of being discharged from the hospital. Cox analysis revealed that 
sarcopenia is associated with longer LOS after considering the confounding effect 
of age, gender, marital status, education, nutritional status, disease severity, 
cognitive impairment and independence in daily living activities. However, after 
stratifying this analysis by age groups, this association was only observed for 
patients aged <65 years. This may be explained by a lower proportion of older 
patients in the study sample (approximately 31%), which leads to a loss of statistical 
power, increasing the possibility of occurrence of a type two error or, alternatively, 
by different clinical characteristics, i.e., the simultaneous presence of several co-
morbidities in older patients could have diminished the strength of the association 
of sarcopenia with LOS. 
This study results increased the knowledge and highlighted the impact of 
sarcopenia on LOS, specifically among hospitalized younger patients (<65 years). 
Besides, as far as we are concerned, there were no previous data concerning 
factors associated with sarcopenia among hospitalized younger patients, with the 
exception for previous results from a recent study undertaken by our research team 
(10).  
Gariballa and Alessa (2013) (7), in a study conducted among hospitalized 
older patients which defined sarcopenia with muscle mass assessed through mid-
arm muscle circumference and muscle function evaluated by HGS, concluded that 
LOS was significantly higher in sarcopenic patients compared with non-sarcopenic 
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patients. Otherwise, in a study conducted by Cerri et al. (2014) (9) among 
hospitalized undernourished older patients, no differences in LOS were found 
between sarcopenic and non-sarcopenic patients. Using similar methodology, our 
results for older patients corroborate Cerri et al. (9) findings. Although present results 
are not in accordance with Gariballa and Alessa, the observed differences between 
studies may be explained by the use of different methodology, BIA and 
anthropometry, in the assessment of muscle mass and by different patients’ 
characteristics. However, our results clearly show a significant association of 
sarcopenia with prolonged LOS for patients aged under 65 years.  
The difference observed for < 65 years and ≥ 65 years groups concerning 
the association of sarcopenia with LOS may be justified by the existence of different 
characteristics, diagnoses and, even, higher severity of co-morbidities between 
younger and older adult patients, besides the possible occurrence of a type two 
error, as hypothesized before in this section.  
The present study results also showed that sarcopenic overweight or obese 
patients (BMI ≥ 25 kg/m2) had a higher probability of being discharged home than 
sarcopenic non-overweight patients. A possible explanation is that overweight (or 
obese) patients presented significantly higher muscle mass than non-overweight 
patients. Thus, characteristics related to overweight and higher muscle mass could 
have introduced a protective effect for being discharged from the hospital. 
Notwithstanding this, due to the presence of overweight or obesity these patients 
may not present obvious frailty physical features. This may have influenced 
caregivers and biased the indication for discharge destination.  
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The present study shows a frequency of sarcopenia among hospitalized older 
adults of 36.4%, being higher than previous reports, 10% from Gariballa and Alessa 
(2013) (7), 25.3% from Smoliner et al.(2014) (8), 26% from Rossi et al. (2014) (11) and 
21.4% from Cerri et al.(2014) (9). These differences may be due to the use of 
different methodology and to patients’ characteristics. This study also identified 
sarcopenia in 18.8% of the hospitalized patients aged under 65 years. However, it 
is noteworthy that cut-off points used were previously defined for use in older adults, 
as sarcopenia was considered as a geriatric condition. This situation may have 
biased present results with a possible under diagnosis of sarcopenia. 
Patients from intensive care units and other critical patients were excluded 
from the present study due to their inability to perform the required functional tests 
to identify sarcopenia. This situation may constitute a study limitation because 
critical patients due to their clinical condition, would be likely to present muscle mass 
depletion and reduced function and, therefore, to be sarcopenic. Furthermore, the 
inclusion of muscle function (physical performance) in the definition and diagnostic 
criteria of sarcopenia may impair the identification of sarcopenia among critical 
patients and patients unable to perform functional tests. Moreover, it is important to 
highlight that HGS of patients unable to stand was measured with individuals on a 
bed. Although a differential may exist between measurements performed with the 
individual in a sitting or lying position, care was taken in order to follow strictly HGS 
measurement protocol (29). Specifically, HGS was obtained from all participants with 
the unsupported elbow (31). 
In the present study, muscle mass was estimated through BIA, instead of 
using Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), the 
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golden standards for quantifying muscle mass, or Dual Energy X-ray Absorptiometry 
(DXA) the selected alternative for estimating muscle mass in research and clinical 
use (1). This could be regarded as a study limitation. However, BIA results are readily 
reproducible and this is an economical, practical and portable method which, used 
under standard conditions, has been found to be a good alternative to DXA (6). 
Although BIA may not be reliable in conditions like heart failure, kidney failure, and 
dehydration, after applying inclusion criteria, not all patients with these conditions 
were excluded. This may have led to a misclassification of muscle mass and 
subsequently to a misclassification of sarcopenia. 
According to hospital discharge records, the proportion of discharged 
patients aged over 65 years was 38.3% in 2012 and 40% in 2013. Our sample 
contains less patients aged over 65 years (31%). This may have resulted in a lower 
representation of an important group of high risk patients, underestimating 
sarcopenia burden. Nonetheless, the diagnostic criteria of sarcopenia 
recommended by the European Consensus necessitate the application of functional 
tests, thus excluding patients who are unable to carry out these tests (9). The lower 
representation of older patients in this sample may be explained by the need to fulfill 
the criteria. 
Several strengths of this study could be highlighted. A large number of 
hospitalized patients composed this study sample, with a wide age range, 18 to 90 
years old. The patients enrolled in the present study were from a multiplicity of 
hospital surgical and medical wards, which ensured a large variety of diagnoses and 
different diseases. These characteristics strengthen the generalizability of our 
results for other hospitalized patients.  
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Survival analysis has the ability of handling data that are censored, which in 
this study were death, transfer, discharge against medical advice and LOS>30 days. 
This allows for a better hospital representation, because it permits the inclusion of 
cases that could not be included with other statistical approaches, namely, with 
follow-up information unavailable after a certain point, which in our study was 30 
days after hospital admission. Nonetheless, only 16 participants (2.4% of the study 
sample) had a LOS longer than 30 days, thus an extended follow-up period probably 
would not have changed the results obtained. 
Although there are some results available concerning mortality and hospital 
readmission for older patients (7, 9, 12), further research is required in order to assess 
short-term and long-term consequences of sarcopenia in hospitalized patients. 
Being male, aged ≥65 years, presenting dependence, being undernourished 
and being admitted to a medical ward are factors associated with sarcopenia among 
hospitalized adult patients. Sarcopenia is independently associated with longer 
LOS, although this association is stronger for patients aged < 65 years. Moreover, 
sarcopenic overweight is associated with a higher probability of discharge to usual 
residence than non-overweight sarcopenia.  
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Abstract 
Background and aims: Data on the association of sarcopenia with costs 
among hospitalized patients are limited to surgical patients. This study aims to 
increase knowledge regarding the association of sarcopenia with these costs among 
a wide-ranging sample of surgical and non-surgical patients. 
Methods: A prospective study was conducted among hospitalized adult 
patients. Sarcopenia was identified according to the European Working Group on 
Sarcopenia in Older People, as low muscle mass, assessed by bioelectrical 
impedance analysis and low muscle function evaluated by handgrip strength. 
Hospitalization cost was calculated for each patient based on discharge diagnosis 
related group codes and determined on the basis of a relative weight value. Costs 
were defined as the percentage of deviation from the cost of a patient with a relative 
weight equal to one. Multivariable linear regression models were performed to 
identify the factors independently associated to hospitalization costs. 
Results: 656 hospitalized patients aged ≥18 years (24.2% sarcopenic) 
composed the study sample. Sarcopenia increased hospitalization costs by €1240 
(95 % CI: €596-1887) for patients aged <65 years and €721 (95% CI: €13-1429) for 
patients aged ≥65 years. Sarcopenic overweight was related to an increase in 
hospitalization costs of €884 (95% CI: €295-1476). 
Conclusion: Sarcopenia is independently related to hospitalization costs. 
This condition is estimated to increase hospitalization costs by 58.5% for patients 
aged <65 years and 34% for patients aged ≥65 years. 
 
Key-words: sarcopenia; body composition; handgrip strength; hospital; cost  
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Introduction 
Sarcopenia is currently defined as a combination of both low muscle mass 
and low muscle function, according to the European Working Group on Sarcopenia 
in Older People (EWGSOP) (1). 
It is estimated that sarcopenia occurs between 5 to 45% of community 
dwelling older adults (2-4). Although this condition has been mainly described in 
older adults, it can also be present in younger individuals. Cherin et al. in a study 
conducted among community dwelling adults (5) showed that 9% of the individuals 
aged between 45 and 54 years and 13.5% of those aged from 55 to 64 years were 
sarcopenic. Previous studies have shown that this condition is highly frequent 
among hospitalized older patients (6-10), ranging from 10% to 37.3% and was 
identified in circa one fifth of patients aged under 65 years (9). 
This condition has been associated with physical disability, low quality of life 
and higher mortality in community dwelling older adults (1, 11). Among hospitalized 
patients, sarcopenia has been related with poor clinical outcome, namely worst 
post-operative outcomes (12-15), higher risk of non-elective readmission (6) and 
higher mortality (6, 8, 16). 
Considering the impact of sarcopenia on both community dwelling and 
hospitalized individuals, healthcare costs of this condition are expected to be high 
(17). However, according to our knowledge, data on the economic burden of 
sarcopenia are limited. One study from 2004 (18), conducted among representative 
samples of American adults aged ≥ 60 years, reported that the estimated healthcare 
cost attributable to sarcopenia defined as the loss of muscle mass was $18.5 billion 
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($10.8 billion in men, $7.7 billion in women). Recent studies from 2013 (19) and 
2015 (20, 21), reported that sarcopenia determined by computed tomography 
scans, was associated with increased costs in major surgery. Nevertheless, the 
impact of sarcopenia on hospitalization costs among a wider variety of patients, from 
surgical and non-surgical wards, remains to be documented. 
Considering the adverse consequences sarcopenia entails among 
hospitalized patients and the financial constraints that healthcare systems often 
face, it is important to recognize and explore the association of sarcopenia with 
hospitalization costs, in order to maximize resources and provide a more effective 
healthcare plan. 
Therefore, the present study aims to increase the knowledge on the 
association of sarcopenia with costs among a wide-ranging sample of hospitalized 
patients. 
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Materials and Methods 
Study sample and design 
A prospective study was conducted in a general and university hospital 
between July 2011 and December 2014. A consecutive sampling method was 
applied in medical and surgical wards. Patients were eligible to participate in the 
study if they were aged 18 years and over, Caucasian, with an expected hospital 
stay longer than 24 hours, conscious, cooperative and capable of providing written 
informed consent. 
Patients unable to perform the handgrip strength (HGS) technique were 
excluded from the study. This impossibility in carrying out HGS measurement was 
defined as an inability to understand verbal instructions or having a condition limiting 
HGS measurement (namely pain). Critically ill patients, i.e., with a life-threatening 
medical or surgical condition requiring intensive care unit level care, presenting 
severe organ system dysfunction and needing for active therapeutic support were 
excluded (22). Pregnancy and patient ward isolation were also defined as exclusion 
criteria. 
According to these criteria, patients admitted to neurology, clinical 
haematology and intensive care unit wards were not recruited whereas participants 
from the following departments were selected: angiology and vascular surgery, 
cardiology, digestive surgery, endocrinology, gastroenterology, hepatobiliary 
surgery, internal medicine, nephrology, non-digestive surgery, orthopaedics, 
otorhinolaryngology and urology. Therefore, from the daily list of inpatients admitted 
to each of these wards, those who fulfilled inclusion criteria were invited to 
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participate in the study, until the number of patients had attained the total number 
of beds of the ward. 
From 992 patients who fulfilled the inclusion criteria and were invited to 
participate, 336 (33.9%) were not included. The reasons were refusals (n=198), 
cognitive impairment (n=13) and missing data (n=125). 
 
Ethics 
This research was conducted according to the recommendations established 
by the Declaration of Helsinki and approved by the Institutional ethics and review 
boards of Centro Hospitalar do Porto. All study participants provided written 
informed consent. 
 
Data collection 
Demographical, clinical data, medical diagnoses and data of hospital 
admission were retrieved from patient's clinical file at the time of evaluation. Date of 
hospital discharge and discharge diagnosis were retrieved from hospital records 
after the patient had left the hospital. All other information was obtained by two 
trained registered nutritionists through a structured questionnaire within 72h of 
admission to the hospital. 
Education was evaluated by the number of completed school years and the 
following categories were created: 0-4, 5-12 and more than 12 years. Marital status 
was categorized as single and not single (married or in a civil partnership, divorced 
and widowed). Cognitive impairment was evaluated with the Abbreviated Mental 
Test (AMT) (23). Independence in activities of daily living was assessed with the 
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Katz index (24) and two categories were defined according to the score obtained: ≤ 
5 - moderate / severe dependence and 6 - independent. Charlson Disease Severity 
Index (25) was recorded by two previously trained interviewers using medical 
discharge diagnoses in the patient's clinical record. 
Patient nutritional status was evaluated with Patient - Generated Subjective 
Global Assessment (PG-SGA) (26). Standing height (cm) was measured with a 
metal tape (Rosscraft, Innovations Incorporated, Surrey, Canada) with a 0.1 cm 
resolution and a headboard. Body weight (kg) was assessed with a calibrated 
portable beam scale with a 0.5 kg resolution. All anthropometric measurements 
were performed by two previously trained registered nutritionists using standard 
methods (27). The intra-and inter-observer technical error of measurement was 
calculated for all measurements, respectively, in 17 and 18 individuals. Intra-
observer ranged from 0.2% to 0.6%, and inter-observer error ranged from 0 to 1.4%. 
These values are considered acceptable for trained anthropometrists (28). 
Sarcopenia was defined according to the EWGSOP as the presence of both 
low muscle mass and low muscle function (1). 
Whole body resistance (ohms) and reactance (ohms) were assessed through 
tetrapolar bioelectrical impedance analysis (BIA) using a Biodynamics Model 450 
(Seattle, Washington USA) with 0.1 ohm resolution, operating at a single frequency 
of 50 KHz. 
Muscle mass was evaluated using the equation of Janssen et al. (2000) (29): 
[(height2/ resistance × 0.401) + (gender × 3.825) + (age × –0.071)] + 5.102, with 
height measured in cm; resistance measured in ohms; for gender, men = 1 and 
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women = 0; age measured in years. Muscle mass was adjusted for height. Gender 
specific cut-off points indicated in the EWGSOP consensus were used (1). 
Muscle function was evaluated by HGS, using a calibrated Jamar® Hydraulic 
Hand dynamometer (Sammons Preston, Bolingbrook, IL, USA), with 0.1 kgf 
resolution. The Jamar® dynamometer is proposed by the American Society of Hand 
Therapists as the gold standard for measurements of HGS (30). Each subject 
undertook three measurements using the non-dominant hand with a one minute 
interval between measurements and the maximum value was selected (31). Low 
HGS was classified using the cut-offs proposed in the EWGSOP Consensus (1): 
less than 30 kgf for men and 20 kgf for women. 
Body mass index (BMI) was determined through the standard formula [weight 
(kg) / height2 (m)] and BMI categories were created according to the World Health 
Organization cut-offs (32). 
 
Statistics 
According to the normality of variables distribution, evaluated through 
Kolmogorov-Smirnov test, results were described as mean and standard deviation 
or as median and interquartile range (IQR) if non-normal distribution. Categorical 
variables were reported as frequencies. 
Hospitalization cost was calculated for each patient based on discharge 
diagnosis related group (DRG) codes. The DRG system is used to calculate hospital 
reimbursements, with the amounts determined on the basis of a relative weight 
value. This weight value reflects the main diagnosis, surgical interventions, 
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pathologies, complications, clinical procedures, medium length of hospital stay, age, 
gender and discharge destination. 
The information about DRG codes and its amounts was obtained from 
Portuguese Ministerial Directive number 839-A, 31 July 2009 (33) for data obtained 
between 2011 and 2012, number 163, 24 April 2013 (34) was used for data obtained 
in 2013 and number 20 from 29 January 2014 (35) was used for data obtained in 
2014. The percentage of cost deviation was calculated from the difference between 
the cost of each patient and the cost of a patient with a relative weight equal to one 
(€2396 for data obtained between 2011 and 2012; €2142 for data obtained in 2013; 
€2120 for data obtained in 2014). Percentage of cost deviation was summarized 
into quartiles using the cutoffs of the sample distribution: ≤-35.3 (24.1%); -35.2,-1.10 
(25.8%); -1.09, 88.4 (24.5%); ≥88.5 (25.6%). 
 Length of hospital stay (LOS) was determined from the date of hospital 
admission and discharge. Length of hospital stay was also dichotomized according 
to a cut-off of 7 days based on the median LOS of the entire sample, and in 
agreement with the median LOS in Portuguese hospitals (36). 
In order to select variables associated with sarcopenia and with percentage 
of cost deviation, patients were compared for several demographic and clinical 
characteristics. All the comparisons were computed using Mann-Whitney test, or 
Student’s t test for independent samples, or Kruskal-Wallis test for continuous 
variables and Pearson χ2 for categorical variables. 
Multivariable linear regression models using stepwise method were 
performed to identify the independent variables associated with percentage of cost 
deviation. The following variables were included in the model: sarcopenia status 
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(categorical), age (continuous), gender (categorical), marital status (categorical), 
Katz index (categorical), education (categorical), nutrition status (categorical), 
hospital ward (categorical), length of hospital stay (categorical), the Abbreviated 
Mental Test score (continuous) and the Charlson comorbidity index score 
(continuous). These variables were included, as they were considered potential 
confounders. 
Statistical significance was set at p < 0.05. All analyses were conducted with 
the Software Package for Social Sciences (SPSS) for Windows (version 20.0; 
SPSS, Inc., Chicago, IL). 
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Results 
Baseline characteristics of the 656 hospitalized patients enrolled in this study, 
according to sarcopenia status are shown in Table 1. Approximately half of patients 
were women (46.1%), age ranged between 18 and 90 years old, median (IQR) = 56 
(22) years. Sarcopenia was highly frequent affecting 24.2% of the participants. 
Sarcopenic patients were older and presented longer LOS than 
non-sarcopenic patients (Table 1). Also, sarcopenic patients were more likely to be 
male, to be undernourished and to present higher Charlson index score than 
non-sarcopenic patients (Table 1). There was a higher proportion of sarcopenic 
patients in medical wards than in surgical wards (Table 1). The highest proportion 
of sarcopenic patients (34.3%) was observed in internal medicine wards.  
Hospitalization costs within the present sample ranged from €387 to €30880, 
median (IQR) of €2369 (€3094). Patients’ characteristics were stratified according 
to the percentage of cost deviation quartiles, as shown in Table 2. Sarcopenic 
patients presented a positive percentage of cost deviation, i.e., these patients 
present a mean cost higher than the cost of a patient with relative weight equal to 
one. Otherwise, the percentage of cost deviation was negative for non-sarcopenic 
patients. Thus, non-sarcopenic patients present a mean cost lower than the cost of 
a patient with relative weight equal to one. 
Compared to patients in the upper quartiles of percentage of cost deviation, 
patients in the lower quartiles had a higher education level, were more likely to be 
single, were less likely to be dependent and presented better nutrition status and 
shorter length of hospital stay (Table 2). The highest proportion of sarcopenic 
patients was found in the highest quartile of percentage of cost deviation distribution. 
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There was a higher proportion of patients admitted to surgical wards in the two upper 
quartiles of percentage of cost deviation (Table 2). 
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Table 1 – Participants’ baseline characteristics according to sarcopenia status. 
  
Non-sarcopenic 
(n=497) 
 
Sarcopenic 
(n=159) 
p 
    
Age (years), median (IQR) 54 (24.0) 64 (19.0) <0.001 a 
Age categories, n (%) 
   < 65 
   ≥ 65 
 
368 (74.0) 
129 (26.0) 
 
85 (53.5) 
74 (46.5) 
 
 
<0.001 b 
Gender, n (%) 
Women 
Men 
 
244 (49.1) 
253 (50.9) 
 
58 (36.5) 
101 (63.5) 
 
 
0.006 b 
Education (years), n (%) 
0-4 
5-12 
>12 
 
184 (37.0) 
270 (54.3) 
43 (8.7) 
 
81 (50.9) 
64 (40.3) 
14 (8.8) 
 
0.005 b 
Marital status, n (%) 
Single 
Not single 
 
91 (18.3) 
406 (81.7) 
 
25 (15.7) 
134 (84.3) 
 
 
0.550 b 
AMT, median (IQR) 10.0 (1.0) 10.0 (1.0) 0.455 a 
Charlson Index, median (IQR) 1.0 (2.0) 2.0 (3.0) 0.002 a 
PG-SGA, n (%) 
Non-undernourished 
Undernourished 
 
299 (60.2) 
198 (39.8) 
 
63 (39.6) 
96 (60.4) 
 
<0.001 b 
Table continued  
  
84 
 
  
Non-sarcopenic 
(n=497) 
 
Sarcopenic 
(n=159) 
p 
Katz index, n (%) 
Independent 
Moderate / severe dependence 
 
482 (97.0) 
15 (3.0) 
 
143 (89.9) 
16 (10.1) 
 
0.001b 
BMI categories, n (%) 
Underweight 
Normal weight 
Overweight /obesity 
 
11 (2.2) 
207 (41.6) 
279 (56.1) 
 
8 (5.0) 
62 (39.0) 
89 (56.0) 
 
0.173b 
Hospital ward, n (%) 
   Medical 
   Surgical 
 
223 (44.9) 
274 (55.1) 
 
96 (60.4) 
63 (39.6) 
 
 
0.001b 
LOS, days, median (IQR) 6.0 (6.0) 9.0 (10.0) <0.001a 
LOS, days, n (%) 
<7 
 ≥7 
 
252 (50.7) 
245 (49.3) 
 
55 (34.6) 
104 (65.4) 
 
 
<0.001b 
HGS (kgf), median (IQR) 
   Women 
   Men 
 
18.0 (9.4) 
35.5 (8.0) 
 
13.0 (6.5) 
23.4 (7.2) 
 
<0.001a 
<0.001a 
SMI (kg/m2), mean (SD) 
  Women 
  Men 
 
8.6 (1.4) 
11.1 (1.5) 
 
6.6 (1.0) 
9.4 (0.8) 
 
 0.003c 
<0.001c 
Percentage of cost deviation (€), median (IQR) -5.1 (103.1) 44.3 (178.5) <0.001a 
 
 IQR, Interquartile range; SD: standard deviation; AMT, Abbreviated Mental Test; PG-SGA, Patient-Generated Subjective Global Assessment;  
 SMI: skeletal muscle mass index (muscle mass / height2); BMI, body mass index; LOS, length of hospital stay; HGS, handgrip strength.  
a Mann-Whitney test; b Chi-square test; c Independent samples  t-Test 
Table 1 continued  
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Table 2 – Participants’ characteristics according to percentage of cost deviation quartiles. 
 
 
                                                Percentage of cost deviation quartiles 
 
 
1st 
≤-35.3 
(n=158) 
 
2nd 
-35.2,-1.10 
(n=169) 
 
3rd 
-1.09,88.4 
(n=161) 
 
4th 
≥88.5 
(n=168) 
p 
Gender, n (%) 
Women 
Men 
 
77 (48.7) 
81 (51.3) 
 
78 (46.2) 
91 (53.8) 
 
69 (42.9) 
92 (57.1) 
 
78 (46.4) 
90 (53.6) 
 
 
0.770a 
Age, median (IQR) 53.0 (30.3) 52.0 (23.0) 58.0 (21.0) 61.0 (18.5) <0.001b 
Education (years), n (%) 
0-4 
5-12 
>12 
 
46 (29.1) 
90 (57.0) 
22 (13.9) 
 
68 (40.2) 
89 (52.7) 
12 (7.1) 
 
65 (40.4) 
80 (49.7) 
16 (9.9) 
 
86 (51.2) 
75 (44.6) 
7 (4.2) 
 
 
0.001a 
 
Marital status, n (%) 
Single 
Not single 
 
35 (22.2) 
123 (77.8) 
 
34 (20.1) 
135 (79.9) 
 
31 (19.3) 
130 (80.7) 
 
16 (9.5) 
152 (90.5) 
 
 
0.013a 
AMT, median (IQR) 10.0 (1.0) 10.0 (1.0) 10.0 (1.0) 9.0 (2.0) 0.081b 
Katz index, n (%) 
Independent 
Moderate/ severe dependence 
 
154 (97.5) 
4 (2.5) 
 
163 (96.4) 
6 (3.6) 
 
156 (96.9) 
5 (3.1) 
 
152 (90.5) 
16 (9.5) 
 
 
0.008a 
PG-SGA, n (%) 
Non-undernourished 
Undernourished 
 
103 (65.2) 
55 (34.8) 
 
100 (59.2) 
69 (40.8) 
 
85 (52.8) 
76 (47.2) 
 
74 (44.0) 
94 (56.0) 
 
 
0.001a 
Sarcopenia, n (%) 
Non-sarcopenic  
Sarcopenic 
 
128 (81.0) 
30 (19.0) 
 
138 (81.7) 
31 (18.3) 
 
128 (79.5) 
33 (20.5) 
 
103 (61.3) 
65 (38.7) 
 
 
<0.001a 
BMI categories, n (%) 
Underweight 
Normal weight 
Overweight / obesity 
 
2 (1.3) 
69 (43.7) 
87 (55.1) 
 
5 (3.0) 
74 (43.8) 
90 (53.3) 
 
8 (5.0) 
54 (33.5) 
99 (61.5) 
 
4 (2.4) 
72 (42.9) 
92 (54.8) 
 
0.232a 
Charlson Index, median (IQR) 2.0 (2.0) 1.0 (2.0) 2.0 (3.0) 2.0 (3.0) 0.264b 
Hospital ward, n (%) 
   Medical 
   Surgical 
 
94 (59.5) 
64 (40.5) 
 
91 (53.8) 
78 (46.2) 
 
81 (50.3) 
80 (49.7) 
 
53 (31.5) 
115 (68.5) 
 
 
<0.001a 
LOS, days, median (IQR) 5 (5) 5(5) 8(7) 9 (9) <0.001b 
LOS, days, n (%) 
   <7 
   ≥7 
 
103 (65.2) 
55 (34.8) 
 
97 (57.4) 
72 (42.6) 
 
64 (39.8) 
97 (60.2) 
 
43 (25.6) 
125 (74.4) 
 
 
<0.001a 
IQR, interquartile range;  AMT, Abbreviated Mental Test; PG-SGA, Patient-Generated Subjective Global 
Assessment; LOS, length of hospital stay;  BMI, body mass index;  
a Chi-square test; b Kruskal-Wallis test; 
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Multivariable linear regression models calculated to predict the percentage of 
cost deviation are presented in Table 3. The analysis was displayed for the entire 
sample (model 1) and according to age groups, <65 years and ≥65 years (models 
2 and 3). Additionally, model 4 considered sarcopenic overweight (sarcopenia 
associated with BMI ≥ 25 Kg/m2) as an independent variable. 
In model 1, being not single, undernourished, admitted to a surgical ward, 
having ≥7 days of hospitalization and being sarcopenic were associated to higher 
hospitalization costs. For patients who were aged < 65 years (model 2), age, 
admission to a surgical ward, undernutrition, ≥7 days of hospitalization and 
sarcopenia were associated to higher percentage of cost deviation. In model 3, for 
patients aged ≥65 years, admission to a surgical ward, ≥7 days of hospitalization 
and sarcopenia were also associated to higher hospitalization costs. Sarcopenic 
overweight or sarcopenic obesity (BMI ≥ 25 kg/m2) was also able to predict a higher 
percentage of cost deviation, together with age, undernutrition, admission to surgical 
ward and length of hospital stay (model 4).  
After adjustment for potential confounders, the economic impact of 
sarcopenia in hospitalization cost in the entire sample it is estimated to be € 1117 
(95% CI: € 644-1588), €1240 (95 % CI: €596-1887) for patients aged < 65 years 
and €721 (95% CI: €13-1429) for patients aged ≥65 years. Sarcopenic overweight 
is estimated to be associated with an increase of €884 (95% CI: €295-1476) in 
hospitalization costs.
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Table 3 – Multivariable linear regression models for prediction of hospitalization cost.  
  
Regression 
coefficient (95% CI) 
 
p 
   
Model 1 (entire sample)   
Marital status (reference: single) 29.8 (5.27-54.2) 0.017 
   PG-SGA (reference: non-undernourished) 27.7 (8.08-47.4) 0.006 
   Hospital ward (surgical vs medical) 66.8 (47.9-85.6) <0.001 
   LOS, days (reference: LOS < 7 days) 62.4 (42.8-81.9) <0.001 
   Sarcopenia (reference: non-sarcopenic) 52.7 (30.4-74.9) <0.001 
   
Model 2 (age < 65 years)   
   Age, years 1.31 (0.37-2.25) 0.007 
   PG-SGA (reference: non-undernourished) 28.5 (3.87-53.2) 0.023 
   Hospital ward (surgical vs medical) 51.8 (28.6-75.0) <0.001 
   LOS, days (reference: LOS < 7 days) 59.0 (35.0-83.0) <0.001 
   Sarcopenia (reference: non-sarcopenic) 58.5 (28.1-89.0) <0.001 
   
Model 3 (age ≥ 65 years)   
   Hospital ward (surgical vs medical) 101.7 (69.5-134.0) <0.001 
   LOS, days (reference: LOS < 7 days) 64.6 (31.2-98.0) <0.001 
   Sarcopenia (reference: non-sarcopenic) 34.0 (0.60-67.4) 0.046 
   
Model 4 (entire sample)   
   Age, years 0.80 (0.19-1.41) 0.010 
   PG-SGA (reference: non-undernourished) 29.3 (9.4-49.1) 0.004 
   Hospital ward (surgical vs medical) 63.8 (45.0-82.7) <0.001 
   LOS, days (reference: LOS < 7 days) 63.8 (44.0-83.5) <0.001 
   Sarcopenic overweight, (reference: non-sarcopenic overweight) 41.7 (13.9-69.6) 0.003 
 
CI, confidence interval; PG-SGA, Patient-Generated Subjective Global Assessment; LOS, length of hospital 
stay. 
Variables included: sarcopenia or sarcopenic overweight status (non-sarcopenic used as reference), age, 
gender (women used as reference), marital status (single used as reference), Katz index (independent used as 
reference), education (dichotomized as 0-4 years and ≥ 5 years; ≥5 years was used as reference), undernutrition 
status according to PG-SGA (non-undernourished used as reference), hospital ward (surgical used as 
reference), length of hospital stay (<7 days used as reference), Abbreviated Mental Test score and Charlson 
comorbidity index score.  
Dependent variable: percentage of cost deviation. 
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Discussion 
The present study results show that sarcopenia is associated with a major 
increase in hospitalization costs, considering the effect of potential confounders. 
After stratifying the model according to age group, this effect was still visible for both 
younger and older adults, in spite of being stronger for younger patients. 
It is worth highlighting that with the exception of sarcopenia, factors 
associated with hospitalization costs changed across the two different age groups. 
While age, undernutrition, being on a surgical hospital ward and length of stay were 
related to higher hospitalization costs for younger patients, in the model carried out 
for patients aged ≥ 65 years, only length of stay and the ward of hospitalization were 
associated with the percentage of cost deviation. Moreover, sarcopenic overweight 
(or obesity) was also a predictor of higher hospitalization costs, even though the 
association was weaker than the one described for sarcopenic patients. 
Additionally, it is worth mentioning that the multivariable linear regression 
model was adjusted for length of hospital stay using a dichotomised variable (< 7 
days, ≥7 days), although medium length of hospital stay is included in the weighing 
value used for calculate hospitalization cost. The inclusion of this variable in the 
multivariable analyses is justified by the existence of an interval of days of 
hospitalization for each DRG code. These defined intervals can be wide-ranging. 
Depending on the interval indicated to each DRG code, the same DRG code can be 
attributable to a patient with a short LOS (< 7 days) and a patient with a longer LOS 
(≥ 7 days). The potential confounding effect of different LOS was, therefore, 
controlled. 
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The present study results increase the knowledge about sarcopenia and 
hospitalization costs by providing an estimation on this association. Sarcopenia 
defined by computed tomography scans was related with higher costs among 
patients who underwent surgery (19, 20, 21).  The ability of HGS, as a single 
parameter in predicting higher hospitalization costs has also been recently 
described (37). However, as far as we are concerned, there were no previous 
reports where sarcopenia was defined as low muscle mass and low muscle function 
and among hospitalized patients with a wide range of diagnoses and age. Therefore, 
due to differences in methodology, these results are not comparable with previous 
reports. The impact of sarcopenia in healthcare costs has been described in the 
United States (18). But, in this report, sarcopenia was defined merely by the loss of 
muscle mass and the observation was not focused on hospitalized patients.  
The inclusion of muscle function (physical performance) in the definition and 
diagnostic criteria of sarcopenia may impair the identification of sarcopenia among 
critically ill patients and patients unable to perform functional tests. This situation 
may constitute a study limitation because these patients due to their clinical 
condition, would be likely to present muscle mass depletion and reduced function 
and, therefore, to be sarcopenic. 
In the present study, muscle mass was assessed with BIA, instead of using 
computed tomography or magnetic resonance imaging which are the golden 
standards for quantifying muscle mass, or dual energy x-ray absorptiometry, the 
selected alternative for estimating muscle mass in research and clinical use (1). This 
could be a study limitation. However, BIA is an economical, practical and 
reproducible method which, used under standard conditions, has been described as 
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a suitable alternative to dual energy x-ray absorptiometry (1). Although BIA may not 
be reliable in conditions like heart failure, kidney failure, and dehydration (29) not all 
patients with these conditions were excluded. This may have caused a 
misclassification of muscle mass and consequently a misclassification of 
sarcopenia.  
According to hospital discharge records, the proportion of discharged older 
patients (aged ≥ 65 years) was 38.3% in 2012 and 40% in 2013.The proportion of  
patients aged over 65 years in our sample contains is lower (31%). This situation 
may have led to a lower representation of an important group of high risk patients, 
underestimating sarcopenia burden. Nevertheless, the diagnostic criteria of 
sarcopenia recommended by the European Consensus, requires the application of 
functional tests, thus excluding patients who are unable to carry out these tests (8). 
The lower representation of older patients in this sample may be explained by the 
need to comply with the criteria. 
The DRG system has been shown to underestimate the real hospitalization 
costs as it reflects only direct hospitalization costs. Indirect costs, as societal costs, 
are not taken into account (38). Nonetheless, this methodology was used in the 
present study as it allows for an assortment of patients with a diversity of diagnoses 
and procedures. 
Several strengths of this study could be emphasized. This sample is 
composed of a large number of hospitalized patients, with a wide age range, from 
18 to 90 years old. The patients enrolled in the present study were from a multiplicity 
of hospital surgical and medical wards, which ensured a variety of diagnoses and 
  
91 
 
diseases. These characteristics strengthen the generalizability of our results for 
other hospitalized patients.  
Further investigation is needed in order to explore the extent of the influence 
of the early identification of sarcopenia in the reduction of adverse outcomes and, 
therefore, the reduction of inherent hospitalization costs. 
In conclusion, present research shows that sarcopenia is independently 
related to hospitalization costs. This condition is estimated to increase 
hospitalization costs in 52.7% (58.5% for patients aged < 65 years and 34% for 
patients aged ≥ 65 years). 
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Abstract 
Background: The present study aims to evaluate the effect of posture on body 
girths assessment among hospitalized adults and older adults. We further explored 
the influence of body mass index on this effect.  
Materials and Methods: A cross-sectional study was conducted among 
hospitalized adult patients. Arm, waist, hip and calf girths were obtained for each 
patient in standing and supine positions. Body girths were obtained in the two body 
positions and differences were compared according to body mass index (BMI) 
normal weight and overweight categories. 
Results: 123 patients (27.6% aged ≥65 years) composed the study sample. 
Significant differences were found between measurements obtained in standing and 
supine positions, ranging from 0.6 to 1.1 cm. Intraclass Correlation Coefficient (ICC) 
values were ≥0.97 and agreement ranged from 81.3% to 87% (weighted k ≥0.84). 
Similar results were found when differences were stratified by BMI categories. 
Conclusion: Although body girths assessment in standing and supine positions in 
hospitalized adults and older adults differ, these differences are small and they are 
not dependent on BMI categories. 
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Introduction 
 Current anthropometry protocols, specifically those for body girths 
assessment, indicate supine position as the correct position for performing 
measurements 1. Nevertheless, in clinical practice, namely in hospital settings, there 
are often individuals who, due to a number of factors, are unable to change their 
body position for girth measurements 2,3. In those cases, it is required to adapt the 
standard technique to the patient’s condition. 
 In the hospital environment, the effect of body posture on measurements is 
of utmost importance because anthropometry is a relevant resource for assessment 
and prognosis prediction. Moreover, body girths are frequently used for body 
composition and nutritional assessment purposes, isolated or as part of 
undernutrition diagnosis and screening tools 4-6.  
A previous report had shown that, among young healthy adults, body posture 
influenced anthropometric measurements of the lower limbs 3. More recently, a 
study conducted among institutionalized and hospitalized older adults (aged ≥65 
years) showed that differences found between body girths obtained in both standing 
and supine positions did not have clinically relevant impact on nutritional status 
classification according to Mini Nutritional Assessment – Short Form and reference 
data percentiles 7.  
Besides body posture, physical complexion can also be a source of error for 
anthropometric assessment and it is not currently known if differences associated 
with body posture are greater when anthropometric measurements are evaluated in 
overweight or obese subjects rather than in individuals with normal weight. 
Anthropometric measurements in obese (or overweight) patients, due to the 
  
102 
 
presence of a larger body size are more susceptible to error, even with a trained 
anthropometrist. This possible influence of obesity (or overweight) in body girths 
assessment needs to be documented, as, in clinical practice, this effect can lead to 
a misinterpretation of anthropometry and, consequently, a misclassification of 
nutritional status. 
According to our knowledge, there is no available information on the effect of 
posture on body girths among adult hospitalized patients aged <65 years. Moreover, 
there are no previous reports on the effect of different body mass index (BMI) 
categories and body complexion in body girths measurement. Therefore, the 
present study aims to evaluate the effect of posture on body girths assessment 
among hospitalized adults and older adults. We further explored the influence of 
body mass index on this effect.   
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Materials and Methods 
Study sample and design 
A cross-sectional study was conducted in a general university hospital. 
Patients were eligible to participate in the study if they were aged 18 years and over, 
Caucasian, conscious, cooperative, capable of changing body position from 
standing to supine and able to provide written informed consent. 
Critically ill patients, i.e., with a life-threatening medical or surgical condition 
requiring intensive care unit level care, presenting severe organ system dysfunction 
and needing for active therapeutic support were excluded 8. Pregnancy and patient 
ward isolation were also defined as exclusion criteria. Patients with BMI <18.5 Kg/m2 
(n=5) were excluded from the analysis. 
This research was carried out according to the recommendations established 
by the Declaration of Helsinki and approved by the institutional ethics and review 
boards. All study participants provided a written informed consent. 
 
Data collection 
Demographical data were obtained by a trained registered nutritionist through 
a structured questionnaire within 72h of admission to hospital. 
Education was evaluated by the number of completed school years and the 
following categories were created: 0-4, 5-12 and more than 12 years. Marital status 
was categorized as single, married or in a civil partnership, divorced and widowed. 
Cognitive impairment was evaluated with the Abbreviated Mental Test (AMT) 9. 
Independence in activities of daily living was assessed with the Katz index 10. 
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Patient nutritional status was evaluated with Nutritional Risk Screening 2002  
11. Standing height (cm) was measured with a metal tape (Rosscraft, Innovations 
Incorporated, Surrey, Canada) with a 0.1 cm resolution and a headboard. Body 
weight (kg) was assessed with a calibrated portable beam scale with 0.5 kg 
resolution. Measurements of the arm, waist, hip and calf girths were performed by 
a previously trained registered nutritionist following standard methods 1 and using a 
metal tape with 1 mm resolution. All measurements were conducted first with the 
subject in a standing position and after with the subject in a supine position. 
The intra- and inter- observer technical error of measurement was calculated 
for all measurements. Intra-observer ranged from 0.2% to 0.6%, and inter-observer 
error ranged from 0 to 1.4%. These values are considered acceptable for trained 
anthropometrists 12,13. 
 BMI was determined through the standard formula [weight (kg) / height2 (m)] 
14 and BMI categories were created according to the World Health Organization 
cut-off values 15. 
 
Statistics 
The normality of variables distribution was tested using Kolmogorov-Smirnov 
test. Results were described as mean and standard deviation (SD). Categorical 
variables were reported as frequencies. Differences between proportions were 
assessed with Pearson χ 2 test. 
Body girths means obtained with the subject in both standing and supine 
positions were compared through Student’s t-test for related samples. Differences 
in body girths means obtained in the two body positions according to BMI categories 
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(normal weight or overweight/obesity) were compared using Student’s t-test for 
independent samples. 
Data set was divided into quartiles, according to the distribution of girth 
measurement values on both standing and supine positions. Association between 
girth measurements obtained in the two body positions was quantified by Intraclass 
Correlation Coefficient (ICC) 16. Agreement between quartiles of girth 
measurements performed in both standing and supine positions was determined 
using the weighted kappa with the Fleiss classification 17 and also by the graphical 
method of Bland and Altman 18. 
Statistical significance was set at p <0.05. All analyses were conducted with 
the Software Package for Social Sciences (SPSS) for Windows (version 20.0; 
SPSS, Inc., Chicago, IL). 
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Results 
 
Baseline characteristics of the 123 patients enrolled in the present study are 
displayed in Table 1, for the entire sample and stratified by age groups. Patients’ 
mean age (SD) was 52.7 (15.7) years and 27.6% patients were aged ≥65 years. 
Younger patients (aged <65 years) presented higher education level, were more 
likely to be single and presented better nutrition status than patients aged ≥65 years. 
The highest proportion of patients was independent according to Katz index. Mean 
BMI was 26.8 (5.1) kg/m2 and 57.7% patients presented overweight or obesity (BMI 
≥25 kg/m2). 
Body girths mean values obtained in both standing and supine positions are 
presented in Table 2. Measurements obtained in standing position were 
systematically higher than measurements obtained in supine position (p ≤0.001). 
The highest difference (1.1 cm) was observed for hip girth. Nevertheless, all ICC 
values correspond to a strong correlation (ICC ≥0.97) 16. Moreover, the agreement 
between measurements is high, ranging from 81.3% to 87% and all kappa values 
correspond to a good agreement (0.80-1.00) according to Fleiss classification 17
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Characteristics 
Entire sample 
(n=123) 
< 65 years 
(n=89) 
≥ 65 years 
(n=34) 
 
p 
     
Age (years), mean (SD) 52.7 (15.7) 45.5 (11.9) 71.3 (5.3) <0.001a 
Gender, n (%) 
  Women 
  Men 
 
57 (46.3) 
66 (53.7) 
 
45 (50.6) 
44 (49.4) 
 
12 (35.3) 
22 (64.7) 
 
 
0.159b 
Education (years), n (%) 
  0-4 
 
44 (35.8) 
 
26 (29.2) 
 
18 (53.0) 
 
 
  5-12 
  >12 
64 (52.0) 
15 (12.2) 
51 (57.3) 
12 (13.5) 
13 (38.2) 
3 (8.8) 
0.049b 
Marital status, n (%) 
  Single 
  Married 
  Widowed 
  Divorced 
 
15 (12.2) 
84 (68.3) 
15 (12.2) 
9 (7.3) 
 
13 (14.6) 
64 (71.9) 
11 (12.4) 
1 (1.1) 
 
2 (5.9) 
20 (58.8) 
4 (11.8) 
8 (23.5) 
 
 
<0.001b 
 
 
Table continued  
Table 1 – Patients’ baseline characteristics for the entire sample and according to age groups. 
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Characteristics 
Entire sample 
(n=123) 
< 65 years 
(n=89) 
≥ 65 years 
(n=34) 
 
p 
 
Katz index, n (%) 
  Independent 
  Moderate and severe dependence 
 
 
120 (97.6) 
3 (2.4) 
 
 
88 (98.9) 
1 (1.1) 
 
 
32 (94.1) 
2 (5.9) 
 
 
 
0.185b 
Nutritional status (NRS-2002), n (%)     
  Normal 
  Risk 
114 (92.7) 
9 (7.3) 
86 (96.6) 
3 (3.4) 
28 (82.4) 
6 (17.6) 
 
0.013b 
BMI (kg/m2), mean (SD) 26.8 (5.1) 27.1 (5.4) 25.8 (3.9) 0.245a 
BMI categories (kg/m2), n (%)     
  Normal weight 
  Overweight and obesity 
52 (42.3) 
71 (57.7) 
36 (40.4) 
53 (59.6) 
16 (47.1) 
18 (52.9) 
 
0.545b 
 
 
 
 
Table 1 continued  
SD: standard deviaton; BMI: body mass index; NRS-2002: Nutritional Risk Screening - 2002 
a Independent samples t-Test 
b Pearson Chi-square test 
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Table 2 – Comparison between body girths in standing and supine positions. 
 
 
SD: standard deviation; CI: confidence interval; ICC: intraclass correlation coefficient;  
a Difference = Girth in standing position - Girth in supine position 
b Student’s t-test for related samples 
c Data in quartiles according to sample distribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
Girths (cm) 
Standing, 
mean (SD) 
Supine, 
mean (SD) 
Differencea  
mean (95%CI) 
 
p b 
 
ICC 
Weighted 
kappac 
Agreement 
(%)c 
        
Arm  29.9 (4.3) 29.2 (4.1) 0.7 (0.6-0.9) <0.001 0.97 0.87 83.7 
Waist  93.2 (14.2) 92.6 (14.0) 0.6 (0.3-0.9) 0.001 0.99 0.89 86.7 
Hip  99.9 (9.9) 98.8 (10.0) 1.1 (0.8-1.4) <0.001 0.99 0.90 87.0 
Calf  35.6 (3.5) 35.0 (3.5) 0.6 (0.5-0.8) <0.001 0.97 0.84 81.3 
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Comparison between the differences in body girths obtained in the two body 
positions across two BMI categories (normal weight and overweight or obesity) are 
presented in Table 3. Mean differences in body girths measured in the two body 
positions did not significantly change between patients with normal weight and 
overweight or obese patients. Agreement, kappa and ICC values are also similar 
between the two BMI categories. 
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Table 3 – Body girths differences for standing and supine positions, comparison between normal weight (n=52) and overweight or obese (n=71) patients. 
 
 
Girths (cm) 
Standing / supine 
difference, 
normal weight 
mean (SD) 
Standing / supine 
difference, 
overweight or 
obesity 
mean (SD) 
 
Differencea, mean 
(95% CI) 
p b 
 
 
Agreement (%)c 
normal weight 
(kappa)d 
 
 
Agreement (%)c 
overweight or obesity 
(kappa)d 
 
 
ICC 
normal weight 
 
 
ICC 
overweight or obesity 
         
Arm  0.6 (1.0) 0.8 (1.1) -0.2 (-0.6-0.1) 0.147 86.5 (0.82) 83.1 (0.80) 0.92 0.97 
Waist  0.2 (0.3) 0.9 (0.2) -0.7 (-1.3-0.04) 0.063 86.5 (0.82) 88.0 (0.89) 0.95 0.99 
Hip  1.2 (0.2) 1.1 (0.2) 0.1 (-0.4-0.6) 0.666 80.8 (0.74) 91.6 (0.91) 0.95 0.98 
Calf  0.6 (0.1) 0.7 (0.1) -0.1 (-0.4-0.1) 0.332 80.8 (0.72) 81.7 (0.81) 0.95 0.97 
 
SD: standard deviation; CI: confidence interval; ICC: intraclass correlation coefficient 
a Difference in positions for girths in normal weight - Difference in position for girths in overweight or obesity 
b Student’s t-test for independent samples 
c Data in quartiles according to sample distribution 
d Weighted kappa
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Bland and Altman graphical representations (Figures 1 to 4) were displayed 
considering the effect of different BMI categories. For all body girths obtained in the 
two body positions it is possible to observe that body girth values are consistently 
higher for overweight or obese patients. There is little dispersion and observed 
differences are not dependent on the magnitude of the measurements for both 
normal weight and overweight patients. These representations corroborate 
graphically the high agreement found for measurements in the two body positions 
and the similarities between normal weight and overweight patients considering this 
agreement. 
Further analysis was carried out in order to assess whether these results 
were different according to <65 years and ≥65 years age groups. Differences 
between body girths obtained in the two body positions were not statistically different 
when stratified by the two age categories, with exception for waist girth in patients 
aged ≥ 65 years (waist girth mean in standing position = 97.1 cm versus waist girth 
mean in supine position = 96.5 cm, p = 0.08) that almost reached the statistical 
significance. Regarding the comparison between normal weight and overweight or 
obesity, there was no change after stratification by age groups. 
      
  
113 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2 - Bland and Altman plot to waist girth (cm) obtained in the standing and supine positions and 
stratified by BMI categories. 
Figure 1 - Bland and Altman plot to arm girth (cm) obtained in the standing and supine positions and 
stratified by BMI categories. 
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Figure 3 - Bland and Altman plot to hip girth (cm) obtained in the standing and supine positions and 
stratified by BMI categories. 
Figure 4 - Bland and Altman plot to calf girth (cm) obtained in the standing and supine positions and 
stratified by BMI categories. 
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Discussion 
 The present study results show there are little posture related differences in 
the assessment of body girths among hospitalized patients.  
Our results corroborate previous findings concerning the effect of posture on 
body girths in older adults 7 and firstly report this effect among hospitalized younger 
patients. For patients aged ≥65 years, it is noteworthy that the absence of 
differences in waist girth measured in standing and supine positions is in 
accordance with a previous report 7, even though sample characteristics differ, i.e., 
not all previous study participants were hospitalized and they were significantly older 
than in the present study (mean age of 77.3 years versus mean age of 71.3 years). 
Considering the effect of BMI categories on body girths obtained in the two 
body positions, no significant differences were found between overweight or obese 
and normal weight patients. As far as we are concerned, there are no previous 
results to which compare these findings. These similarities reveal that, for a trained 
anthropometrist, body complexion does not appear to modify the differences 
between standing and supine positions. Thus, the assessment of arm, waist, hip or 
calf girths in an overweight or obese bedridden patient does not have a greater 
influence from body posture than the assessment of a patient with normal weight. 
These observations are substantiated by Bland and Altman graphical results. 
Therefore, and in contrast to what was theoretically expected, body girths 
assessment of bedridden obese patients does not differ from the assessment of 
bedridden normal weight patients. 
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In the present analysis, BMI was used as a surrogate indicator of body 
complexion. Although it is well-recognized and universally used for clinical purpose, 
this index does not consider important variables for body composition assessment, 
other than weight and height 19. Moreover, BMI is not the most accurate health 
status predictor, as demonstrated in a previous study 20 where, using waist girth 
results, for a given waist girth value, overweight or obese and normal weight 
individuals had comparable health risks. 
Even though the main aim of this study was to explore the influence of a high 
BMI value compared to a normal BMI value, the exclusion of patients with a BMI of 
<18.5 Kg/m2 could limit the external validity of present results for individuals in this 
condition. However, only five patients (4.1%) were excluded, thus, the hypothetical 
inclusion of those individuals was not likely to change the results obtained here. 
In order to comply with the inclusion criteria, patients unable to change their 
body position were not included in the study. It remains to be documented if in 
bedridden patients body girths measurement could be more biased than in patients 
without mobility restraints, namely due to physical inactivity and muscle disuse. 
Sample size allowed for detecting differences and patients in the present 
sample were from different hospital wards, which ensured variety of conditions and 
body composition patterns. 
The present sample mean BMI (26.8 kg/m2) corresponds to overweight 
classification and 57.7% patients were overweight or obese. Results could 
potentially be different if evaluated within populations with other BMI categories 
distribution.  
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Future research should explore this effect among other hospitalized patients 
and community-dwelling individuals, with higher and lower BMI and also, among 
other ethnic groups. In conclusion, body girths assessment in standing and supine 
positions in hospitalized adults and older adults differ. However, these differences 
are small and they are not dependent on BMI categories. 
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Abstract 
Background: Triceps skinfold (TSF) compressibility can introduce error on the 
measurement and its interpretation. However, it has not been explored yet in a 
clinical setting. Lipotool® is a digital calliper which acquires 60 measures per second 
and firstly allows the study of compressibility. Therefore, the present study aims to 
explore through an innovative technique, TSF compressibility and its associated 
factors among a sample of hospitalized patients. 
Methods: A cross-sectional study was conducted among hospitalized adult 
patients. Evolution of tissue compressibility during two seconds was registered and 
120 TSF values were obtained. Compressibility was determined according to time 
(τ) and according to the difference between the initial value and the final value (TSF 
difference). Multivariable linear regression models were performed in order to 
identify factors associated with TSF compressibility. 
Results: 106 patients (30.2% aged ≥65 years) composed the study sample. Time 
of compressibility (τ) was no significantly associated with any of the studied 
variables, but compressibility based on TSF difference was independently 
associated with TSF thickness (regression coefficient (95% CI) = 0.38 (0.01-0.05), 
p= 0.002) and nutritional risk (regression coefficient (95% CI) = 0.23 (0.12-1.23), p= 
0.018). 
Conclusion: Among a sample of hospitalized patients, time of compressibility (τ) 
was not affected by any of the studied factors. However, undernutrition risk and 
the TSF thickness were factors independently associated with higher 
compressibility assessed by the difference between the initial and final TSF value.  
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Introduction 
 
Skinfold thickness is often used for body composition assessment due the 
accessibility, the non-invasive features and the ability to measure subcutaneous 
adiposity (1, 2). 
 In skinfold thickness measurement with a skinfold calliper, a constant 
pressure is applied for a defined period of time (3, 4). The tissue’s dynamic response 
to this pressure is defined as compressibility (1, 5). This characteristic has been 
studied by comparing skinfold calliper measurements and subcutaneous fat 
thickness assessed by coarse methods such as imaging methods, cadaver studies 
and empiric comparisons (1, 5). 
There are underlying suppositions on the estimation from skinfold  
measurement: skin thickness is negligible, adipose tissue has constant 
characteristics and also that proportion of subcutaneous to visceral fat is equivalent 
in all subjects (1). Notwithstanding this, it has been previously shown that 
compressibility varies according to the sites of measurement and between 
individuals, influencing the relation between the measurement and the actual 
adipose tissue thickness, introducing error in the estimation of body fatness (1, 5).    
Gender (5), age (6), hydration status (6), skin thickness (7), subcutaneous tissue 
pressure (7) and site of measurement (8) have been previously described as factors 
associated with compressibility. Nevertheless, over the past few years, knowledge 
on compressibility has not significantly increased. 
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An integrated system, Lipotool®, was recently developed. This equipment 
consists of a digital skinfold calliper and a software application (9). The system 
acquires 60 measurements per second (9). Thus, this novel methodology firstly 
permits the study of dynamic tissue’s response evolution during the measurement(9). 
From all skinfold thickness sites, triceps skinfold (TSF) is the most used in 
clinical practice, as, along with mid-arm circumference, it integrates mid-arm muscle 
circumference formula, a simple method that allows for the estimation of muscle 
mass (10). 
Regarding the wide use of TSF, the minimization of error is of utmost 
importance in order to provide an adequate use and interpretation for clinical 
practice. Nonetheless, as far as we are concerned, skinfolds compressibility has not 
been explored yet in a clinical setting. Therefore, the present study aims to explore 
through an innovative technique, TSF compressibility and its associated factors 
among a sample of hospitalized patients. 
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Materials and Methods 
 
 
Study sample and design 
A cross-sectional study was conducted in a general university hospital. 
Patients were eligible to participate in the study if they were aged 18 years and over, 
Caucasian, conscious, cooperative and able to provide written informed consent. 
Critically ill patients, i.e., with a life-threatening medical or surgical condition 
requiring intensive care unit level care, presenting severe organ system dysfunction 
and needing for active therapeutic support were excluded (11). Pregnancy and 
patient ward isolation were also defined as exclusion criteria. 
 
Ethics  
This research was carried out according to the recommendations established 
by the Declaration of Helsinki and approved by the institutional ethics and review 
boards of Centro Hospitalar do Porto. All study participants provided a written 
informed consent. 
 
Data collection 
Demographical data were obtained by one trained registered nutritionist 
through a structured questionnaire within 72 hours of admission to hospital. 
Education was evaluated by the number of completed school years and the 
following categories were created: 0-4, 5-12 and more than 12 years. Marital status 
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was categorized as single, married or in a civil partnership, divorced and widowed. 
Independence in activities of daily living was assessed with the Katz index (12).  
Patients’ nutritional status was evaluated with Nutritional Risk Screening 
(NRS) 2002 (13). Standing height (cm) was measured with a metal tape (Rosscraft, 
Innovations Incorporated, Surrey, Canada) with a 0.1 cm resolution and with a 
headboard. Body weight (kg) was assessed with a calibrated portable beam scale 
with 0.5 kg resolution. 
Triceps skinfold thickness (mm) was obtained with Lipotool® digital calliper 
after performing the measurement during two seconds, as established by the 
protocol (3). 
All measurements were performed by the same trained registered nutritionist. 
The intra- and inter- observer technical error of measurement was calculated for all 
measurements. Intra-observer ranged from 0.2% to 0.9%, and inter-observer error 
ranged from 0 to 6.6%. These values are considered acceptable for trained 
anthropometrists (14, 15). 
Body mass index (BMI) was determined through the standard formula [weight 
(kg) / height2 (m)] (16) and BMI categories were created according to the World Health 
Organization cut-offs (17). 
 
Statistics 
Results were described as mean and standard deviation (SD) or as median 
and interquartile range (IQR) according to normality of distribution, assessed with 
Kolmogorov - Smirnov test. 
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Data on TSF measurements were provided by Lipotool® software and the 
evolution of tissue compressibility during two seconds was registered, as this 
method acquires 60 measurements per second. Thus, in the end of the 
measurement, 120 values were obtained. 
Therefore, compressibility was determined according to a method based on 
τ, tau, a measurement of time expressed in seconds, that reflects adipose tissue 
dynamic response to compression, being an individual characteristic. Thus, lower τ 
values mean that the skinfold compress faster, and, therefore, presents higher 
compressibility. τ value was obtained after computing the inverse of the exponent of 
a regression equation displayed for the 120 measurement sets of each patient. 
Alternatively, another method was used to define compressibility. This 
method was based on the difference computed between the initial value and the 
final value, from the 120 TSF measurements acquired by the digital calliper. Thus, 
high difference between initial and final TSF value corresponds to high 
compressibility.  
Data set was divided into tertiles of TSF, tertiles of τ and tertiles of difference 
between TSF initial and final value (TSF difference), according to the sample 
distribution. In order to select variables associated to compressibility, patients’ 
baseline characteristics were compared across τ tertiles and TSF difference tertiles. 
Patients’ baseline characteristics were also compared across TSF tertiles. 
All the comparisons were computed by One-way ANOVA test if distribution 
was normal, or Kruskal-Wallis test, if non-normal distribution. Categorical variables 
were reported as frequencies. Differences between proportions were assessed with 
Pearson χ 2 test. 
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Furthermore, multivariable linear regression models were built in order to 
identify the independent variables associated with compressibility, assessed by τ or 
as TSF difference. The following variables were included in the models: TSF value 
(continuous), age (continuous), nutritional status (categorical) and gender 
(categorical), as these variables were considered as being potential confounders or 
covariates. 
Statistical significance was set at p < 0.05. All analyses were conducted with 
MATLAB (MathWorks, Inc., Natick, MA) and the Software Package for Social 
Sciences (SPSS) for Windows (version 20.0; SPSS, Inc., Chicago, IL). 
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Results 
 
Baseline characteristics of the 106 patients enrolled in the present study are 
displayed in Table 1, for the entire sample and stratified by TSF tertiles. Mean age 
(SD) was 53.1 (15.8) and 30.2% patients were aged ≥65 years.  There were 56.6% 
overweight or obese patients and 11.3% patients were at undernutrition risk (Table 
1). The highest and the lowest time of compressibility (τ) were observed for patients 
in the 2nd TSF tertile and in the 1st TSF tertile, respectively. The highest TSF 
difference was observed for patients in the 3rd TSF tertile (Table 1).  
As shown in Table 2, patients’ characteristics did not differ across τ tertiles, 
with exception for TSF difference, which was higher in the 2nd and 3rd τ tertiles than 
in the 1st τ tertile. Otherwise, BMI, TSF thickness and τ value increased from the 1st 
to the 3rd TSF difference tertiles (Table 3). 
 
  
132 
 
   
 
 
 
 
 
 
 
 
 
Entire sample 
 
(n=106) 
1st  
≤11.5 
(n=35) 
2nd 
11.8-21.2 
(n=34) 
3rd 
≥21.3 
(n=37) 
 
p 
 
Age (years), mean (SD) 
 
53.1 (15.8) 55.5 (15.7) 53.5 (13.8) 47.0 (16.9) 0.066a 
Age categories (years), n (%) 
  <65 
  ≥65 
 
 
74 (69.8) 
32 (30.2) 
 
 
23 (65.7) 
12 (34.3) 
 
 
23 (67.6) 
11 (32.4) 
 
 
28 (75.7) 
9 (24.3) 
 
 
 
0.258b 
 
Gender, n (%) 
  Women 
  Men 
 
 
49 (46.2) 
57 (53.8) 
 
 
1 (2.9) 
34 (97.1) 
 
 
19 (55.9) 
15 (44.1) 
 
 
29 (78.4) 
8 (21.6) 
 
 
 
<0.001b 
 
Education (years), n (%) 
  0-4 
 
41 (38.7) 
 
9 (25.7) 
 
17 (50.0) 
 
15 (40.5) 
 
 
  5-12 
  >12 
54 (50.9) 
11 (10.4) 
20 (57.1) 
6 (17.1) 
14 (41.2) 
3 (8.8) 
20 (54.1) 
2 (5.4) 
0.188b 
 
 
Marital status, n (%) 
  Single 
  Married 
  Widowed 
  Divorced 
 
 
15 (14.2) 
72 (67.9) 
12(11.3) 
7 (6.6) 
 
 
6 (17.1) 
23 (65.7) 
5 (14.3) 
1 (2.9) 
 
 
3 (8.8) 
25 (73.5) 
5 (14.7) 
1 (2.9) 
 
 
6 (16.2) 
24 (64.9) 
2 (5.4) 
5 (13.5) 
 
 
 
0.310b 
 
 
 
Katz index, n (%) 
     
  Independent 
  Moderate and severe dependence 
103 (97.2) 
3 (2.8) 
33 (94.3) 
2 (5.7) 
34 (100) 
0 (0) 
36 (97.3) 
1 (2.7) 
 
0.359b 
 
Nutritional status (NRS-2002), n (%) 
 
 
 
 
 
 
 
 
 
  Normal 
  Risk 
94 (88.7) 
12 (11.3) 
28 (80.0) 
7 (20.0) 
30 (88.2) 
4 (11.8) 
36 (97.3) 
1 (2.7) 
 
0.068b 
BMI (kg/m2), mean (SD) 
 
26.2 (6.0) 22.6 (5.4) 26.1 (3.5) 29.7 (6.3) <0.001a 
BMI categories (kg/m2), n (%) 
  Underweight or normal weight 
  Overweight or obesity 
 
46 (43.4) 
60 (56.6) 
25 (71.4) 
10 (28.6) 
12 (35.3) 
22 (64.7) 
9 (24.3) 
28 (75.7) 
 
<0.001b 
TSF (mm), mean (SD) 
 
19.1 (12.1) 8.6 (2.0) 16.9 (2.9) 31.7 (11.1) <0.001a 
τ (s), median (IQR) 
 
0.16 (0.16) 
 
0.15 (0.13) 
 
0.23 (0.14) 
 
0.16 (0.11) 
 
0.015c 
 
TSF difference (mm) d, median (IQR) 
 
0.87 (1.02) 
 
0.60 (0.98) 
 
0.72 (0.94) 
 
1.2 (1.3) 
 
0.007c 
 
TSF: triceps skinfold; SD: standard deviation; IQR: interquartile range; BMI: body mass index; 
 NRS-2002: Nutritional Risk Screening – 2002; 
a One-way ANOVA;  
b Pearson Chi-square test;  
c Kruskal-Wallis test ;  
d Triceps skinfold difference: Initial value - Final value, across a set of 120 measurements 
Table 1 – Patients’ baseline characteristics for the entire sample and according to triceps skinfold tertiles. 
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1st  
≤0.13 
(n=35) 
2nd 
0.14-0.23 
(n=35) 
3rd  
≥0.23 
(n=36) 
 
p 
Age (years), mean (SD) 
 
54.4 (14.6) 
 
 
54.0 (15.6) 
 
 
50.9 (17.4) 
 
 
0.591a 
 
Age categories (years), n (%) 
  <65 
  ≥65 
 
23 (65.7) 
12 (34.3) 
 
 
24 (68.6) 
11 (31.4) 
 
 
27 (75.0) 
9 (25.0) 
 
 
 
0.682b 
 
Gender, n (%) 
  Women 
  Men 
 
13 (37.1) 
22 (62.9) 
 
 
17 (48.6) 
18 (51.4) 
 
 
19 (52.8) 
17 (47.2) 
 
 
 
0.394b 
 
Education (years), n (%) 
  0-4 
 
11 (31.4) 
 
15 (42.9) 
 
15 (41.7) 
 
 
  5-12 
  >12 
 
19 (54.3) 
5 (14.3) 
16 (45.7) 
4 (11.4) 
19 (52.8) 
2 (5.6) 
0.669b 
 
Marital status, n (%) 
  Single 
  Married 
  Widowed 
  Divorced 
 
 
6 (17.1) 
23 (65.7) 
5 (14.3) 
1 (2.9) 
 
4 (11.4) 
22 (62.9) 
6 (17.1) 
3 (8.6) 
 
5 (13.9) 
27 (75.0) 
1 (2.8) 
3 (8.3) 
 
 
0.472b 
 
 
Katz index, n (%)     
  Independent 
  Moderate and severe dependence 
 
34 (97.1) 
1 (2.9) 
34 (97.1) 
1 (2.9) 
35 (97.2) 
1 (2.8) 
 
0.984b 
Nutritional status (NRS-2002), n (%)     
  Normal 
  Risk 
28 (80.0) 
7 (20.0) 
34 (97.1) 
1 (2.9) 
32 (88.9) 
4 (11.1) 
 
0.077b 
 
BMI (kg/m2), mean (SD) 
 
25.9 (6.0) 
 
26.3 (4.0) 
 
26.3 (7.5) 
 
0.952a 
 
BMI categories (kg/m2), n (%) 
    
  Underweight or normal weight 
  Overweight or obesity 
16 (45.7) 
19 (54.3) 
15 (42.9) 
20 (57.1) 
15 (41.7) 
21 (58.3) 
 
0.940b 
 
TSF (mm), mean (SD) 
 
18.9 (13.6) 
 
18.0 (9.2) 
 
21.1 (13.0) 
 
0.542a 
 
τ (s), median (IQR) 
 
0.09 (0.04) 
 
0.16 (0.05) 
 
0.33 (0.14) 
 
<0.001c 
 
TSF difference (mm)d, median (IQR) 
 
 
0.61 (1.0) 
 
 
0.75 (1.1) 
 
 
1.19 (1.2) 
 
 
0.026c 
 
Table 2 – Patients’ baseline characteristics according to time of compressibility (τ) tertiles of sample distribution. 
TSF: triceps skinfold; SD: standard deviation; IQR: interquartile range; BMI: body mass index;  
NRS-2002: Nutritional Risk Screening – 2002; 
a One-way ANOVA;  
b Pearson Chi-square test;  
c Kruskall-Walis test;  
d Triceps skinfold difference: Initial value - Final value, across a set of 120 measurements 
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1st  
≤0.53 
(n=34) 
2nd 
0.54-1.27 
(n=36) 
3rd  
≥1.28 
(n=36) 
 
p 
Age (years), mean (SD) 
 
56.1 (14.3) 
 
 
52.9 (17.2) 
 
 
50.4 (15.7) 
 
 
0.418b 
 
Age categories (years), n (%) 
  <65 
  ≥65 
 
23 (67.6) 
11 (32.4) 
 
 
24 (66.7) 
12 (33.3) 
 
 
27 (75.0) 
9 (25.0) 
 
 
 
0.703c 
 
Gender, n (%) 
  Women 
  Men 
 
10 (29.4) 
24 (70.6) 
 
19 (52.8) 
17 (47.2) 
 
20 (55.6) 
16 (44.4) 
 
 
0.056c 
 
Education (years), n (%) 
  0-4 
 
10 (29.4) 
 
14 (38.9) 
 
17 (47.2) 
 
 
  5-12 
  >12 
 
19 (55.9) 
5 (14.7) 
20 (55.6) 
2 (5.6) 
15 (41.7) 
4 (11.1) 
0.434c 
 
Marital status, n (%) 
  Single 
  Married 
  Widowed 
  Divorced 
 
 
1 (2.9) 
24 (70.6) 
6 (17.6) 
3 (8.8) 
 
6 (16.7) 
23 (63.9) 
5 (13.9) 
2 (5.6) 
 
8 (22.2) 
25 (69.4) 
1 (2.8) 
2 (5.6) 
 
 
0.169c 
 
 
Katz index, n (%)     
  Independent 
  Moderate and severe dependence 
 
33 (97.1) 
1 (2.9) 
35 (97.2) 
1 (2.8) 
35 (97.2) 
1 (2.8) 
 
0.999c 
Nutritional status (NRS-2002), n (%)     
  Normal 
  Risk 
 
31 (91.2) 
3 (8.8) 
33 (91.7) 
3 (8.3) 
30 (83.3) 
6 (16.7) 
 
0.459c 
BMI (kg/m2), mean (SD) 
 
24.9 (4.1) 26.6 (7.0) 
26.9 (6.3) <0.001b 
BMI categories (kg/m2), n (%)     
  Underweight or normal weight 
  Overweight or obesity 
 
19 (55.9) 
15 (44.1) 
13 (36.1) 
23 (63.9) 
14 (38.9) 
22 (61.1) 
 
0.199c 
TSF (mm), mean (SD) 
 
14.2 (7.1) 20.6 (12.4) 
22.8 (14.0) <0.001b 
τ (s), median (IQR) 
 
0.13 (0.08) 0.20 (0.24) 
0.21 (0.20) 0.002d 
TSF difference (mm), median (IQR) 
 
0.30 (0.18) 
 
0.83 (0.44) 
 
1.92 (1.6) 
 
<0.001 
 
Table 3 – Patients’ baseline characteristics according to triceps skinfold difference a tertiles of sample distribution. 
TSF: triceps skinfold; SD: standard deviaton; IQR: interquartile range;BMI: body mass index;  
NRS-2002: Nutritional Risk Screening – 2002; 
a: Triceps skinfold difference:nitial value  - Final value, across a set of 120 measurements; 
b One-way ANOVA;  
c Pearson Chi-square test;  
d Kruskall-Walis test 
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Results from the multivariable linear regression models are presented in 
Table 4. As shown in Model 1, time of compressibility (τ) was not significantly 
associated with any of the included variables. In contrast, as displayed in Model 2, 
compressibility based on TSF difference was associated with TSF magnitude 
(regression coefficient=0.38 (0.01-0.05), p=0.002) and nutritional status (regression 
coefficient=0.23 (0.12-1.23), p=0.018), after adjusting for age and gender. Thus, 
presenting higher TSF value, i.e., a thicker TSF, and being at risk of undernutrition 
are factors apparently related to an increase in the difference between TSF initial 
and final value, meaning that the skinfold was more compressed and, therefore, 
presents higher compressibility. 
 
Table 4 – Multivariable linear regression models for prediction of triceps skinfold (TSF) 
compressibility.  
  
Regression 
coefficient (95% CI) 
 
p 
   
Model 1a   
  TSF 0.03 (-0.01-0.01) 0.824 
  Gender (reference: women) -0.06 (-0.37-0.21) 0.599 
  Age  -0.4 (-0.01-0.01) 0.695 
  Nutritional Status (NRS-2002; reference: normal) 0.16 (-0.71-0.08) 0.112 
Model 2b   
TSF 0.38 (0.01-0.05) 0.002 
   Nutritional Status (NRS-2002; reference: normal) 0.23 (0.12-1.23) 0.018 
 
CI: confidence interval; TSF: triceps skinfold thickness (mm); NRS-2002: Nutrition Risk Screening 2002 
Variables included: age (years; continuous), nutrition status according to NRS-2002 (normal used as reference), 
gender (women used as reference) and TSF value (mm; continuous) 
a:. Dependent variable: TSF compressibility defined as time (τ) 
b Dependent variable: TSF compressibility computed as TSF initial value – TSF final value, across a set 120 
measurements  
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Discussion 
 
 The present study results show that quantification of compressibility and its 
associated factors is dependent on the method used for describe this adipose tissue 
feature. 
When compressibility was defined as time, i.e., the time taken by the adipose 
tissue to respond to the pressure exerted by the calliper, differences were observed 
between TSF thickness tertiles, which could indicate that the skinfold magnitude 
was associated with compressibility. In addition, it is worth noticing that patients in 
the 2nd TSF tertile presented higher τ than patients in the 3rd TSF tertile. However, 
after performing a multivariable linear regression model, no independent association 
was found for any of the included variables, showing that, apparently, time of 
compressibility was not influenced by any of the studied factors. 
In contrast, when compressibility was defined as the difference between initial 
and final TSF values obtained by the digital calliper, only BMI and time of 
compressibility differed between the tertiles of this variable. Nevertheless, after 
adjustment for potential confounders, such as gender and age, results from the 
multivariable linear regression model showed that undernutrition risk and the TSF 
magnitude were factors associated with an increase in compressibility, even though 
these associations were not strong, as demonstrated by the low regression 
coefficients obtained. 
Explanations for these associations can be formulated, although only in a 
theoretical perspective as, with the present data, it is not possible to confirm them. 
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Therefore, a thicker TSF presents larger area of adipose tissue and this increase 
the potential of being compressed. Otherwise, an individual classified as being at 
risk of undernutrition is potentially likely to present more laxity in skin and adipose 
tissue, which can influence skinfolds compressibility towards higher values. 
Transposing the present results for clinical practice, TSF thickness and 
undernutrition risk are characteristics susceptible of affecting the association 
between the actual value and the calliper reading, potentially introducing error by an 
increase in adipose tissue compressibility. Thus, by causing more compression in 
the skinfold, this error can lead to an underestimation of TSF thickness, i.e., to a 
lower value reading, and, therefore, to a misinterpretation of the measurement.  
Moreover, once τ indicates skinfolds compressibility, as time of response to 
a constant pressure, a higher time of response is expected to be associated to lower 
compressibility, as the tissues compress slowly. In contrast, a higher difference 
between the initial and final TSF value means that the tissue went through more 
compression, and is, therefore, associated with higher compressibility. 
Notwithstanding this, our results show that τ and TSF difference vary in the same 
direction, as τ values are higher in TSF difference 2nd and 3rd tertiles and TSF 
difference values are higher in the 2nd and 3rd tertiles of τ. 
Considering the aforementioned methods for evaluating compressibility and 
the results actually obtained, there is an apparent counterintuitive observation. 
Nevertheless, it is worth noticing that these two methods are related with two 
different aspects of compressibility, time of response and the skinfold dimension. 
Thus, a skinfold that takes more time to be compressed and is, therefore, less 
compressible according to this definition, may simultaneously present a higher 
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difference between the value in the beginning of the measurement and the value 
attained when the process is complete. 
Although this novel methodology has been previously used in other settings 
(18), as far as we are concerned, this is the first report on the exploration of TSF 
compressibility as a quantifiable variable and its associated factors in a clinical 
setting. Consequently, there are no previous results to which compare our findings. 
Even though one approach detected consistent associations and the other one did 
not, they cannot be compared in terms of accuracy as these two methods assess 
different features. 
 Notwithstanding this, and in a clinical perspective, the absence of association 
with other factors found for compressibility defined as time is not sufficient to 
assume that there are no differences or even that compressibility did not affect 
measurements performed in the present sample. We can further hypothesize that, 
in the two seconds the measurement is performed, τ may be related to a more 
precocious moment of the process than the TSF difference. Thus, it is not known if 
in a larger period of measurement these results could be different. 
 Present results concern TSF only. As it has been already documented 
through results from studies (5,8,19) using different methodologies, adipose tissue 
compressibility varies according to the site of measurement. Thus, it is not known 
whether these results would be different if other skinfolds were evaluated. 
In order to comply with the inclusion criteria, no critically ill or functionally 
impaired patients were enrolled. Moreover, the majority of the participants were 
independent in activities of daily living and there was a small proportion of patients 
at nutritional risk. Thus, the present sample can be considered homogenous and 
  
139 
 
this feature may have influenced the results obtained. Therefore, it is not known if 
present results would be different in a wider sample of hospitalized patients or, even, 
among critically ill or bedridden patients. 
In the future, it would be important to further explore compressibility through 
the present methodologies in other settings, such as in community-dwelling adults 
and older adults and different ethnic groups. The application of the present methods 
in different settings could allow for both testing their reproducibility and improving 
the techniques used. 
In conclusion, among a sample of hospitalized patients, time of 
compressibility (τ) was not affected by any of the studied factors. However, 
undernutrition risk and the TSF thickness were factors independently associated 
with higher compressibility assessed by the difference between the initial and final 
TSF value. Although the present study is merely an exploratory attempt to describe 
compressibility and its effects, our results emphasize the need for further research 
in order to determine the most accurate method to quantify compressibility, to infer 
on the associated factors and to control its effect. 
 
Acknowledgements 
The authors thank Centro Hospitalar do Porto and all ward directors for 
facilitating the data collection. The authors also thank Eng.º Tiago Faustino Andrade 
from UISPA-INEGI, FEUP, for the assistance given in the statistical analysis. 
The authors declare no conflicts of interest. 
  
140 
 
References 
 
1. Lohman TG. Skinfolds and body density and their relation to body fatness: a 
review. Hum Biol. 1981; 53(2):181-225. 
 
2. Clarys JP, Provyn S, Marfell-Jones MJ. Cadaver studies and their impact on 
the understanding of human adiposity. Ergonomics. 2005; 48(11-14):1445-61. 
 
3. Marfell-Jones M OT, Stewart A, Carter L. International standards for 
anthropometric assessement.  Potchefstroom, South Africa: ISAK; 2006. 
 
4. Lohman TG, Roche AF, Martorell R. Human body composition  2nd ed.  
Champaign, IL: Human Kinetics; 2005. 
 
5. Martin AD, Drinkwater DT, Clarys JP, Daniel M, Ross WD. Effects of skin 
thickness and skinfold compressibility on skinfold thickness measurement. Am J 
Hum Biol. 1992; 4(4):453-60. 
 
6. Brozek J, Kinzey W. Age changes in skinfold compressibility. J Gerontol. 
1960; 15:45-51. 
 
7. Hattori K, Okamoto W. Skinfold compressibility in Japanese university 
students. Okajimas Folia Anat Jpn. 1993; 70(2-3):69-77. 
 
8. Himes JH, Roche AF, Siervogel RM. Compressibility of skinfolds and the 
measurement of subcutaneous fatness. Am J Clin Nutr. 1979; 32(8):1734-40. 
 
9. Amaral TF, Restivo MT, Guerra RS, Marques E, Chousal MF, Mota J. 
Accuracy of a digital skinfold system for measuring skinfold thickness and estimating 
body fat. Br J Nutr. 2011; 105(3):478-84. 
 
  
141 
 
10. Jelliffe DB. The assessment of the nutritional status of the community (with 
special reference to field surveys in developing regions of the world). Monogr Ser 
World Health Organ. 1966; 53:3-271. 
 
11. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric 
patients. JPEN J Parenter Enteral Nutr. 2002; 26(1 Suppl):1SA-138SA. 
 
12. Katz S. Assessing self-maintenance: activities of daily living, mobility, and 
instrumental activities of daily living. J Am Geriatr Soc. 1983; 31(12):721-7. 
 
13. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening 
(NRS 2002): a new method based on an analysis of controlled clinical trials. Clin 
Nutr. 2003; 22(3):321-36. 
 
14. Pederson D, Gore C. Anthropometry Measurement Error.  Sydney, Australia 
University of New South Wales Press; 1996. 
15. Zerfas AJ. Checking Continuous Measures: Manual for Anthropometry.  Los 
Angeles, CA: Division of Epidemiology, School of Public Health, University of 
California, Los Angeles; 1985. 
16. Quetelet A. Anthropometrie ou measure des différentes facultés de l'homme.  
Bruxelles, Belgique: C. Muquardt; 1869. 
 
17. Physical status: the use and interpretation of anthropometry. Report of a 
WHO Expert Committee. World Health Organ Tech Rep Ser. 1995; 854:1-452. 
 
18. Quintas MR, Andrade TF, Restivo MT, M.F. C, Amaral TF. LipoWise: A New 
Generation of Skinfold Callipers. Sensors & Transducers. 2015; 185( 2):162-69. 
  
19. Martin AD, Ross WD, Drinkwater DT, Clarys JP. Prediction of body fat by 
skinfold calliper: assumptions and cadaver evidence. Int J Obes. 1985; 9 Suppl 
1:31-9. 
  
142 
 
 
  
  
143 
 
 
 
 
 
 
 
 
General discussion 
 
  
  
144 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
145 
 
General discussion 
  
The present work intends to increase the existing knowledge on the burden 
and the diagnosis of sarcopenia in a clinical perspective. The results reveal a high 
frequency of sarcopenia amongst hospitalized patients, not only in older adults aged 
65 years or over, but also in younger patients aged between 18 and 64 years. This 
importantly demonstrates that this condition is not merely a geriatric syndrome, as 
previously documented. Besides, the co-existence of sarcopenia with other 
conditions such as undernutrition and overweight or obesity corroborates the 
multifactorial nature of sarcopenia. 
 Several factors, such as male gender, age ≥65 years, dependence on 
activities of daily living, undernutrition and admission to a medical ward, were 
independently associated with a sarcopenia diagnosis. In a clinical setting, it would 
be relevant to further explore these associations and to recognize the modifiable 
factors, in order to act on the prevention of sarcopenia. In the present results, 
undernutrition is the only identified modifiable factor. This finding corroborates the 
major advantage of undernutrition prevention in the avoidance of co-morbidities and 
also emphasizes the importance of timely undernutrition risk screening in clinical 
settings. 
 It is also shown that sarcopenia is independently associated with longer 
length of hospital stay but, after stratification by age categories, this association was 
only identified for adult patients aged less than 65 years old. The absence of 
association of sarcopenia with LOS among older patients is in agreement with a 
previous report (9) and contradicts another report (7). Nevertheless, as discussed 
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before in Chapter I.b, the disparity between studies may be due to different 
methodologies and dissimilar sample characteristics, such as the existence of 
different diagnoses and, even, higher severity of co-morbidities in older patients. 
In regards to the investigation on the financial burden of sarcopenia in the 
hospital setting, it is shown in the present work that this condition is independently 
associated with increased hospital costs, especially among younger patients. It is 
worth noticing that the association of sarcopenia and LOS is reflected in the financial 
impact of sarcopenia, as LOS is closely related to higher hospitalization costs.  
Moreover, association of sarcopenia with LOS was found to be present only 
among hospitalized younger patients. Hospitalization costs, although shown to be 
associated with both age groups, presented a stronger association among 
hospitalized patients aged 18 to 64 years. These findings for LOS and 
hospitalization costs may be explained by the presence of different clinical 
characteristics between younger and older adult patients. The simultaneous 
presence of several co-morbidities in older patients could have diminished the 
strength of the association of sarcopenia with clinical outcomes, such as LOS. 
Consequently, the financial impact of sarcopenia is also lower in older patients than 
in younger patients. 
Notwithstanding this, it is important to consider the limitation related to the 
use of DRG codes. This system has been shown to underestimate the real 
hospitalization costs as it reflects only direct hospitalization costs and does not take 
into account indirect costs, as societal costs (96). Nevertheless, this methodology 
was used in the present study as it allows for an assortment of patients with a 
diversity of diagnoses and procedures. Therefore, the present work provides an 
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original and a broader perspective on the consequences that sarcopenia entails in 
a hospital setting. 
 As previously mentioned in this thesis, the simultaneous presence of 
sarcopenia with other conditions, such as overweight or obesity, was also assessed 
and explored. Therefore, besides the associations found for sarcopenia, sarcopenic 
overweight (or obesity) was by itself independently associated with longer LOS and 
increased hospitalizations costs when patients in those conditions were compared 
to non-sarcopenic patients.  
Overweight sarcopenic patients had shorter hospitalizations compared to 
non-overweight sarcopenic patients. This was an unexpected finding. Although 
there is no previous information to which to compare this observation, it importantly 
reveals that overweight and obesity could have a protective effect in sarcopenic 
patients during the hospitalization process. This protective effect associated with 
overweight and obesity complies with previous evidence on the “obesity paradox”. 
This phenomenon has been observed in a range of cardiovascular disease 
pathologies where overweight and obese patients paradoxically present better 
outcomes than normal weight or underweight patients (97-99). A possible explanation 
for this counterintuitive finding is the protective role of overweight once a disease 
takes hold, as it increases the individual’s chance to cope with treatment and with 
the adverse consequences. 
 Considering the present work findings directly related to sarcopenia, it is of 
major importance to address a few concerns.  
Firstly, the cut-offs from European Consensus (3) used in the diagnosis of 
sarcopenia were created for older individuals and in the present work they were 
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applied to younger adult patients, as there are no age-specific recommended 
cut-offs values available in literature. Thus, this may have caused an 
underestimation of sarcopenia frequency. 
In addition, BIA was used to assess muscle mass. Although this technique is 
recommended by the EWGSOP (3), there are a number of inherent limitations to its 
use in the clinical practice, such as the lack of reliability in the assessment of patients 
with conditions like heart failure, kidney failure, and dehydration (52). The 
non-exclusion of all patients with these conditions may have introduced a 
misclassification of muscle mass, and, subsequently, some sarcopenic patients may 
have not been identified. This may have led to an underestimation of sarcopenia 
frequency. 
Furthermore, the diagnostic criterion of sarcopenia requires the performance 
of functional tests, which leads to the exclusion of critically ill patients and individuals 
with functional impairment. As these individuals are potentially the most susceptible 
to present sarcopenia, this is an important limitation of the current definition of this 
condition. In the present work, this restriction in the participants may limit the 
comparison between studies in regards to critical patients, making the present 
results impossible to generalize for those individuals. 
This concern was already addressed in a recent study by Cerri et al.(9) carried 
out within a sample of 103 hospitalized elderly patients. These authors reported a 
prevalence of sarcopenia of 21.4% but noticed the inability of EWGSOP criteria to 
be satisfactorily applied in 22.3% patients who were not able to perform gait speed 
test and/or handgrip strength due to an acute physically disabling illness.  
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Even though the EWGSOP Consensus lists and recommends the most 
suitable techniques and cut-offs, the lack of standardization of diagnostic criteria 
leads to difficulties in comparing different studies (6). Present results show that the 
frequency of sarcopenia is strongly dependent on the technique used for estimate 
muscle mass. Moreover, anthropometric measures are not recommended due to 
higher susceptibility to error (3). As expounded in Chapter I.a, muscle mass 
estimated through mid-arm muscle circumference was associated with a 
considerably lower frequency of sarcopenia than with muscle mass assessed by 
BIA, which corroborates this EWGSOP position in regards to anthropometric 
measures. 
Notwithstanding the limitations concerning the use of anthropometric 
measures for sarcopenia diagnosis, and as described in a previous section of this 
report, body girths and skinfold thickness, are still valuable resources for use in other 
purposes of clinical practice, due to their financial and accessible features. 
Another aim of this work was to assess the effect of possible sources of error 
on body girths and triceps skinfold thickness, mainly because arm circumference 
and triceps skinfold thickness are included in mid-arm muscle circumference 
formula. It allows for the estimation of muscle mass and, subsequently, can be used 
in the diagnosis of sarcopenia. Thus, exploring potential sources of error could lead 
to the recognition and also to provide clues in order to minimize anthropometric 
measurement bias, consequently, developing and improving the anthropometric 
methodology of sarcopenia diagnosis. 
In regards to body girths, it was initially hypothesised that body posture and 
body complexion, defined by BMI, could influence body girths measurement. The 
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results show that, although existent, in adults and older adults, posture related 
differences are small and individual body complexion does not affect the differences 
observed between the measurements obtained in the two body positions. 
Concerning triceps skinfold assessment, the present work used an innovative 
technique to objectively document and quantify compressibility, which has been 
considered a potential source of error by affecting the relationship between the 
skinfold thickness measured by the calliper and the actual skinfold thickness value 
(90). Regarding skinfolds compressibility defined as time of compressibility, τ, tau, 
and after exploring possible factors associated with this characteristic, there was a 
lack of association between the studied variables. In contrast, when compressibility 
was inferred from the difference between initial and final TSF values, nutrition status 
and triceps skinfold values were found to be independently associated with higher 
compressibility, showing that compressibility could increase according to nutrition 
status and the magnitude of triceps skinfold measurement. This discrepancy 
demonstrates a need to further explore these methodologies in order to identify and 
control the effects of compressibility on TSF assessment. 
Considering the development of the method based on anthropometric 
measurements that leads to sarcopenia diagnosis, the present work brought to light 
a number of issues. The recognition of small posture and physical complexion 
related errors associated to body girths assessment and the advancement in the 
possibility to quantify skinfolds compressibility, are potentially useful insights 
concerning the use of anthropometric measures. Nonetheless, further work should 
document if the theoretical control for the explored sources of error could increase 
the validity of those measurements. 
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Future perspectives 
 
Regarding the techniques involved in sarcopenia diagnosis, besides 
comparing BIA with anthropometric measures, the comparison of sarcopenia 
diagnosis by BIA with those obtained with more precise methods such as DXA, CT 
and MRI, will further reveal differences in the frequency of sarcopenia. However, 
this analysis was not performed in the present work. In the future, it could be 
revealing to explore those comparisons between the aforementioned methods in 
order to further validate the use of BIA for sarcopenia diagnosis purpose. 
Considering the issues the present reports addressed, the development of 
cut-offs specific for sarcopenia diagnosis in younger individuals is a relevant stage 
to reach. Moreover, it would be important to propose new specific cut-offs for the 
estimation of muscle mass based on anthropometric measures, taking into account 
the acquired knowledge on body circumferences. Besides, the possibility to 
determine skinfolds compressibility may allow for the development of corrected 
measurement protocols.  
It would also be important to explore factors associated to skinfolds 
compressibility extending the analyses to other skinfolds, such as biceps, 
subscapular and iliac crest, that are also often used for body composition 
assessment purpose, and to improve the validity of the current technique used to 
determine compressibility. 
The significant limitation concerning the exclusion of critically ill and 
functionally impaired patients the current definition of sarcopenia demands, should 
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be further explored. It would be advantageous to improve the current diagnostic 
criteria of sarcopenia towards the inclusion of those patients. 
In the future, it will be of utmost importance to carry on the effort on the 
development of the most suitable method for the diagnosis of sarcopenia and to 
reach a universal consensus in order to improve the comparison between studies, 
a crucial condition to the progress of investigation. Moreover, it would be also 
important that all sarcopenic patients were suitable to be identified, not only the 
individuals who are able to comply with the current diagnostic criteria.  
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Conclusions 
 
The present work leads to the following overall conclusions: 
 
In regards to sarcopenia burden among hospitalized patients: 
 
1. Sarcopenia is frequent among hospitalized patients and this frequency varies 
widely depending on the applied diagnostic criteria. Sarcopenia was 
identified in a considerable proportion of adult patients between 18 and 64 
years and in those who were non-undernourished, namely among overweight 
and obese. 
2. Being male, aged ≥65 years, being dependent, being undernourished and 
being admitted to a medical ward were factors identified as being associated 
with sarcopenia among hospitalized adult patients. Sarcopenia is 
independently associated with longer LOS, although this association is 
stronger for patients aged 18 to 64 years. Moreover, sarcopenic overweight 
was associated with a higher probability of discharge home than 
non-overweight sarcopenia. 
3. Sarcopenia is independently associated with hospitalization costs, increasing 
costs in 52.7% (58.5% for patients aged < 65 years and 34% for patients 
aged ≥ 65 years). 
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Concerning anthropometric measures and its feasibility for clinical practice: 
 
1. Body girths assessment in standing and supine positions in hospitalized 
adults and older adults differ. However, these differences are small and they 
are not dependent on BMI categories. 
2. Among a sample of hospitalized patients, time of compressibility (τ) was not 
affected by any of the studied factors. However, undernutrition risk and the 
TSF thickness were factors independently associated with higher 
compressibility assessed by the difference between the initial and final TSF 
value. Although this is an exploratory attempt to describe compressibility and 
its effects, our results emphasize the need for further research in order to 
determine the most accurate method to quantify compressibility, to infer on 
the associated factors and to control its effect. 
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